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In biological systems, the formation of molecular complexes is the currency for all cellular
processes. Traditionally, functional experimentation was targeted to single molecular
players in order to understand its effects in a cell or animal phenotype. In the last few
years, we have been experiencing rapid progress in the development of ground-breaking
molecular biology tools that affect the metabolic, structural, morphological, and
(epi)genetic instructions of cells by chemical, optical (optogenetic) and mechanical
inputs. Such precise dissection of cellular processes is not only essential for a better
understanding of biological systems, but will also allow us to better diagnose and
fix common dysfunctions. Here, we present several of these emerging and innovative
techniques by providing the reader with elegant examples on how these tools have been
implemented in cells, and, in some cases, organisms, to unravel molecular processes in
minute detail. We also discuss their advantages and disadvantages with particular focus
on their translation to multicellular organisms for in vivo spatiotemporal regulation. We
envision that further developments of these tools will not only help solve the processes
of life, but will give rise to novel clinical and industrial applications.
Keywords: protein interactions, signaling pathways, cell communication, optogenetics, gene editing, synthetic
biology, gene expression regulation, controlling behavior
INTRODUCTION
For millennia, our species has tried to control the environment around us to facilitate our activities.
This has led to technological inventions from housing to space-probes that (crash) land on a
different planet. Yet, when it comes to living organisms, our control over their behaviors has only
been partial. Initial works have been done using small molecules to activate or inhibit (hopefully)
single cellular functions. Later on, gene augmentation or elimination has been the focus of much of
cell biology, as well as transgenic and knockout (KO)models, for the last two decades. With this, we
have attempted to understand what occurs when a gene is inhibited/removed, or if we can influence
the phenotype of cells or organisms by adding or exchanging genes (knock-in, KI) (Figure 1).
Although, these experiments have produced a trove of valuable data, it can be considered as
just the first steps to real control of phenotypical changes. A novel branch of molecular biology,
called synthetic biology, has stepped in by providing a suite of innovative tools that enable an
unprecedented control of cellular processes, and eventually organisms. Synthetic biology mainly
involves the rational design and engineering of novel biological devises, or systems, by coupling
different biological parts or modules (Kelwick et al., 2014).
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FIGURE 1 | Traditional ways to study organisms, either by introducing or deleting genes and expecting phenotypical changes. (A) An analogy using a car
as a “complex” system, where changes in the components of the car by adding (transgenic, TG), deleting (KO) or replacing/repairing (KI) “parts” (representing genes).
Can we one day use parts to create a whole?; (B) The main reason why we would like to control living systems is to control how one cell behaves and in this way,
determine what it does e.g. differentiation. The tools to achieve such fates are only beginning to come of age.
In this review, some of the most innovative tools for
the detailed manipulation of cellular processes are presented,
discussing their advantages and disadvantages, as well as their
potential translational application to multicellular organisms
which would be the final goal.
RIGHT TO ASSEMBLE
Cells systematically use protein assembly or dissociation as cues
to perform the most complex of biological functions. Therefore,
the manipulation of protein-protein interactions is essential for
the development of any cell controlling system.
Since proteins are the workhorses of cells, these have been the
main focus of most of the research involving control of cellular
behavior. Proteins interact with each other, as well as with other
components of the cell, which is done in an incredibly active
manner. Virtually all cellular processes involve the formation
of protein complexes, frequently involving RNA, DNA, and/or
other biological molecules, too.
Location, Location, Location
One of the most important factors affecting protein function is
localization. Where the protein locates determines its interaction
partners and thus its functions. Cells sort proteins using a
series of encoded signal peptides (or localization signals) within
the protein, analogous to postcodes, that determine where
the protein should be transported e.g., to the nucleus, to
mitochondria, to the cell membrane, or to be secreted. Signal
peptides were first described by Günter Blobel and Bernhard
Dobberstein in a landmark paper (Blobel and Dobberstein, 1975)
that eventually lead to the Nobel prize in Physiology or Medicine
for Blobel in 1999.
The modification of these signals results in changes in the
localisation of proteins and hereby their functions. This can
be used to our advantage, for example localization signals
can be added to exogenous proteins (usually encoded in a
plasmid) so their localisation is predetermined. Adding a nuclear
localisation signal (NLS) to virtually any protein would result
in protein re-routing to the cell nucleus. The reverse process
is also possible, using nuclear export signal (NES) to export
a protein out of the nucleus. Having both NLS/NES will
result in the protein being shuttled between cytoplasm and the
nucleus.
Likewise, mitochondrial targeting signals (MTS) have been
used to attach proteins to the mitochondria’s outer membrane
for many different reasons, e.g., to label mitochondria by use
of fluorescent proteins (FPs) or sequestering proteins to the
mitochondria membrane (see below).
Experimental swapping of localization signals are impressive
tools to study protein function as shown in the following study.
Cytoskeleton remodeling proteins Ena (Mammalian Enabled
Homolog) and VASP (Vasodilator-Stimulated Phosphoprotein)
are cytosolic proteins often found in focal adhesions and leading
edge of fibroblasts, and so assumed to play crucial roles in
remodeling of the actin cytoskeleton that promote cell motility.
Using localisation signals, Bear and collaborators studied Ena
or VASP by either sequestering onto the mitochondrial outer
membrane or directing them to the cell membrane, thus
to the vicinity of focal adhesions, of fibroblasts. Against all
expectations, Ena/VASP sequestration resulted in cytoskeleton
remodeling and increased cell motility, whereas constitutive
cell membrane localization reduced motility (Bear et al.,
2000). This study highlights the importance of detailed
experimentation at the molecular level to unravel cellular
functions.
Localization can be used to bring proteins together or
to separate them. For example, we found an extremely rare
mutation in the gene that codes for a secreted protein, the
luteinising hormone beta (LHB), in a patient. To prove that
the wildtype (WT) and mutant proteins were expressed at the
same level, but only the mutant was intracellularly retained, we
fused the LHB to mCherry fluorescent protein, for tracking, and
to (NLS)AmCyan via a 2A peptide. The 2A peptide is a self-
cleaving peptide the separates the two proteins assuring both are
expressed at equal concentrations. While the WT LHB-mCherry
was normally secreted, and only visible inside secretion vesicles,
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the mutant was intracellularly retained. Nuclear-AmCyan was
then used to quantify for equal expression (Potorac et al.,
2016).
A drawback of localization signals is their uncontrollability.
Therefore, the next section is about additional modifications used
to manipulate protein localization.
The discovery that small compounds can either induce the
dimerization or stabilization of some proteins, has prompted
their use to regulate protein-protein interactions or protein levels
in the cell, respectively.
The Chemistry between Us
One of the best well-described methods where a small compound
triggers protein dimerization involves rapamycin, a macrolide
antifungal antibiotic from Streptomyces hygroscopicus.Originally,
rapamycin was found to form a functional complex with
the FKBP protein (FK506-binding protein, aka FKBP12), a
complex that specifically binds, and inhibits, the mammalian
TOR complex 1 (mTORC1). The mTOR’s domain, which
directly interacts with rapamycin-FKBP moiety, was named
FRB (FKBP–rapamycin binding domain of mTOR) (Chung
et al., 1992; Sigal and Dumont, 1992). The reciprocal affinity
of these two rapamycin-binding domains (FKBP and FRB) has
been underpinned for the development of chemical-inducible
dimerization (CID) (Banaszynski et al., 2005), where two proteins
of interest (POI) or two complementing fragments of a protein,
are each fused to either FKBP or FRB and thereby can be united
by addition of rapamycin (Figure 2A). Below we describe a
couple of well-designed applications on how CID has been used
to understand and control cellular functions.
During the last checkpoint in mitosis, M or spindle
checkpoint, one of the most sophisticated protein complexes
in the cell is meticulously assembled. The complex ensures
that the sister chromatids are aligned and attached to the
microtubule spindles via kinetochores. Once kinetochores are
correctly attached to the spindle, the checkpoint is inactivated by
protein dissociation and cell division can furthermore proceed.
In order to determine which of the checkpoint proteins are able
to reactivate the checkpoint, Ballister, Riegman, and Lampson
used CID to temporarily re-localize checkpoint proteins to the
kinetochore. They fused the mitotic association protein Mis12,
a component of the kinetochore, with FKBP and green FP
(GFP), and FRB was fused to mCherry and checkpoint Mad1
protein. In the presence of rapamycin, Mad1 was recruited into
the kinetochore, as visualized by GFP/mCherry, triggering the
reactivation of the mitotic checkpoint to confirm that Mad1 is a
crucial checkpoint component (Ballister et al., 2014; Ballister and
Lampson, 2016).
Fusing FRB and FKBP domains, surprisingly, does not result
in a molecular clamp in the presence of rapamycin, instead it
forms FRB-FKBP tetramers: where the FKBP of one moiety
dimerises with the FRB of another, occurring thrice more, the
last FKBP binds to the first FRB. The cellular gatekeeper p53
plays essential roles in cycle arrest, senescence, apoptosis, and
DNA damage repair by regulation of the expression of hundreds
of genes. A tetrameric conformation of p53 is required to bind
to target DNA, which is normally achieved via a tetrameric
FIGURE 2 | Chemical-induced dimerization and protein stabilization.
(A) The FKBP/FRB system based on rapamycin-induced protein dimerization.
This system brings two protein, or two complementing fragments, together,
when one is fused to FKBP and the second to FRB in the presence of
rapamycin (Rapa). (B) The fusion of a destabilizing domain (DD) to a protein of
interest (POI) leads to its rapid degradation by the proteasome. However, in
the presence of a suitable ligand [Shield1 for FKBP or Trimethoprim (TMP) for
DHFR] the DD is stabilized and the POI accumulates in the cell.
domain. Therefore, the DNA binding domain of p53 was fused
to FRB-FKBP. Upon addition of rapamycin, the engineered p53
tetramerised and activated target genes—an inducible p53 for
detailed studies in p53’s tumor suppression functions (Inobe
et al., 2015).
The FKBP/FRB dimerization has been widely used, more
in-depth examples can also be found in the following reviews
(Putyrski and Schultz, 2012; DeRose et al., 2013; Feng and
Arnold, 2016). A drawback in the use of rapamycin is that it
targets mTOR which is a master regulator of cell growth and
metabolism (Li et al., 2014; Fischer et al., 2016).
Exploiting CID plus delocalization, Robinson and colleagues
generated a technique they named knocksideways (a British
expression meaning “to take by surprise”) where FRB is
anchored to the outer membrane of the mitochondria via a
mitochondria targeting signal (MTS). FRB-MTS functions as a
trap for FKBP-fused proteins in the presence of rapamycin—
sequestering proteins away from their site of action. Using
knocksideways the authors sequestered the adaptor protein 2 (AP-
2), normally recruited to endocytotic vesicles, and demonstrated
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that clathrin-mediated endocytosis of transferrin requires AP-2
(Robinson et al., 2010). Knocksideways is able to control a cellular
process by temporarily sequestering key molecular components.
While this procedure is fast and allows immediate removal
of molecular players, avoiding compensations common in
long knockdown (silencing) or knockout (KO) experiments, it
requires the removal, by silencing or KO, of the endogenous
POI, or more sophisticatedly a knock-in (KI), inserting FKBP
as a fusion tag to the endogenous gene of interest. Although
this domain could be easily adapted to exogenous proteins in
synthetic biology, the side effects of rapamycin are an issue
nevertheless.
An Act of Disappearance and
Reappearance
Protein turnover is determined by its degradation rate—mostly
performed by the proteasome. Misfolded or aged proteins are
labeled with a small protein tag called ubiquitin by ubiquitin
ligase, then such ubiquitinated proteins are mostly routed to the
proteasome for rapid degradation (Hershko et al., 1980).
The first system based on the control of protein stability was
reported in the middle of the 90s. A mutant of mammalian
dihydrofolate reductase bearing an N-terminal arginine (Arg-
DHFR), was shown to be unstable at 37◦C but stable at lower
temperatures (∼23◦C) in yeast (Dohmen et al., 1994; Lévy
et al., 1999). Interestingly, addition of the DHFR inhibitor,
methotrexate, partially protected Arg-DHFR from degradation
(Lévy et al., 1999), which was suggested as a potential method
to control protein degradation.
Subsequently, the laboratory of Thomas Wandless developed
two destabilization domains (DDs), that are rapidly destabilized
and degraded by the proteasome. The first is a 107 residues
long (12-kDa) FKBP derivative (DD-FKBP) which is stabilized
by a ligand, named morpholino-containing ligand (Shield-1)
(Banaszynski et al., 2006; Haugwitz et al., 2008). The second was
based on the Arg-DHFR, but instead, using prokaryotic E. coli
dihydrofolate reductase (ecDHFR) mutants that were engineered
to be unstable in the absence, but stabilized in the presence,
of the cell-permeable prokaryotic-DHFR inhibitor trimethoprim
(TMP) (Iwamoto et al., 2010; Figure 2B).
DD-FKBP/Shield-1 and DD-ecDHFR/TMP have been used
in living cells and animal models (An et al., 2015) including
the accumulation of a reporter DD-yellow fluorescent protein
(DD-YFP) in the brain of rats, transduced by a lentivirus, after
TMP was administrated in drinking water (Iwamoto et al., 2010;
Tai et al., 2012). Moreover, with the use of DD-ecDHFR/TMP,
Quintino and collaborators were able to control the level of
glial cells-derived neurotrophic factor (GDNF), a protein that
exerts neurotrophic and neuroprotective effects on dopamine
neurons, in a rodentmodel of Parkinson’s disease (Quintino et al.,
2013) confirming the great therapeutic potential of GDNF against
Parkinson’s disease.
TMP has several advantages: it acts on prokaryotic ecDHFR
with virtually no effect on mammalian DHFR, has low toxicity,
and is able to cross the blood-brain barrier. Moreover, these two
systems (DD-FKBP/Shield-1 and ecDHFR/TMP) can be used
orthogonally, and both inhibitors do not seem to have any major
side effects in animal models. The cell specificity in vivo could
be achieved by using tissue-specific promoters; further, protein
accumulation is reversible. Conversely, DDs are large proteins
that can cause secondary structural effects to the fused protein,
the accumulation kinetics will be strongly influenced by gene
expression and inhibitor doses, and they cannot be regulated at
the subcellular level.
All abovementioned systems are based in the stabilization
of domains that otherwise destine the fusion protein for
degradation. Can a protein be removed at will? The auxin-
inducible degron (AID) was originally discovered in plants
(Nishimura et al., 2009) and subsequently optimized for
mammalian cells (Fallis, 2009; Morawska and Ulrich, 2013).
Auxins, such as indole-3-acetic acid (IAA), function as hormones
regulating gene expression in plants (Fallis, 2009). Proteins
having an AID tag are normally expressed, yet, in the
presence of IAA, they interact with F-box protein TIR1,
an interaction that triggers ubiquitination by E3 ligase and
consequently proteasomal degradation (Morawska and Ulrich,
2013) in 0,5–2 h (Zhang et al., 2015; Wood et al., 2016).
AID has also been successfully adapted to the nematode
Caenorhabditis elegans, where the main component of AID, TIR1,
was expressed under the control of different promoters to drive
tissue- and stage-specific expression. While the AID tag was
introduced into endogenous nuclear hormone receptors nhr-
23 and nhr-25 genes, as well as meiosis-specific gene dhc-1
(dynein heavy chain) using CRISPR/Cas9 technology (see below).
Upon addition of auxin both of the nuclear receptors were
dynamically removed, demonstrating that the decrease of NHR-
25 receptor produced larval arrest, molting defects and gonads
abnormalities, whereas auxin-induced NHR-23 depletion was
associated with larval arrest only. Auxin-induced degradation
of DHC-1 protein exerted defects in chromosome synapsis,
included global disorganization of germline nuclei and defects
in oocyte maturation in Caenorhabditis, which proves its crucial
role in meiosis (Zhang et al., 2015).
Ongoing efforts to develop more potent auxin agonists are
on the way, although the properties of IAA (water solubility,
size, low toxicity, and a low cost) may prove difficult to
improve upon. The need of small molecules in all chemical-
induced systems, produces a series of challenges for translation
to in vivo. These small molecules should not interact with
other cellular components, have minimal-to-none toxicity and
immunogenicity, and should be delivered to all tissues, or, in
some cases, to specific tissues. An additional challenge for most
small molecules is to pass through the blood-brain or blood-testis
barriers.
THE FIRST-LIGHT ON OPTOGENETICS
Expectedly, plants, algae and bacteria have proteins that respond
to light. Indeed, even animals have proteins that respond to
light—such as the opsin receptors. Although, in animal opsins
receptors are G protein-coupled receptors (GPCRs) while in
microorganisms opsin receptors are ion channels instead. The
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pioneer of these ion receptors, cloned from Chlamydomonas
reinhardtii, was channelrhodopsin-2 (ChR2). This cation channel
was customized to mammalian cells, proving its functionality
by transfecting neurons and exposing them to blue-light (470
nm), which induced polarization by admitting sodium in Nagel
et al. (2003) and Boyden et al. (2005). This was followed by the
Natronomonas pharaonis halorhodopsin (NpHR) chloride pump
(Zhang et al., 2007), a yellow-light sensing receptor (589 nm),
which allows chlorine ions into cells, enabling to turn firing
neurons off (Figure 3A).
The immediate success of these receptors, prompted a search
in plants, fungi, bacteria and algae for novel proteins that
are able to react to light. What has been found so far is a
fascinating collection of proteins that change function upon light
activation. Due to the characteristics of light, these light-sensing
proteins respond to different wavelengths, some of them only to
short wavelength windows while others respond distinctively to
different light hues.
As a proof of concept, ChR2, NpHR, and a new red-
light (566 nm) activated protein pump, Arch (archaerhodopsin;
Chow et al., 2010), were introduced into the brains of mice
using Cre-conditional adeno-associated viral vectors, in which
Cre recombinase (see Box 3) expression was controlled by
neuron-type specific promoters: parvalbumin for expression in
GABAergic interneurons, and somatostatin for expression in
basolateral amygdala principal neurons. Only the parvalbumin-
or somatostatin-positive cells developed light sensitivity to the
correct wavelength. In this manner, the authors managed to
control the activation of fear memory without a conditioned
stimulus—in this case, a sound associated with a footshock—
or inhibited fear responses upon auditory stimulation (Wolff
et al., 2014). In a separate study, the photosensitive ChR2 and
NpHR ion channels were expressed in the cortical amygdala
neurons of mice under the control of the arc promoter—
specific to these neurons. Activation of the cortical amygdala
neurons by odors secreted by predators, such as TMT (2,4,5
dihydro 2,5 trimethylthiazoline), produce defensive behavior in
mice. Light-activation of NpHR silenced the olfactory bulb and
suppressed the aversion to TMT, while ChR2 activation induced
the defensive response in the absence of TMT (Figure 3B). With
this, the authors demonstrated that, by optogenetical affecting
the neural circuit that transmits information from the olfactory
bulb to cortical amygdala, they can control the innate behavior of
animals (Root et al., 2014).
Neurons are not alone to respond to an influx of ions,
muscle cells respond by contracting upon sodium influx. Based
on this, Park et al. layered ChR2-expressing cardiomyocytes
in a serpentine pattern on a ray fish-shaped elastomer with a
gold skeleton—to retract to the original shape, in an attempt
to create prototypes for organ bioengineering. Photoactivation
triggered sequential muscular contractions, creating undulatory
phototactic locomotion of this biorobot (it swam in direction to
light!) (Park et al., 2016).
Since red-light has a better tissue penetrance, is less absorbed
by blood, and does not appear to interfere with normal
visual function, a green-light-responding channelrhodopsin
from Volvox carteri has been engineered to respond to orange-
to-red wavelengths (590–630 nm) (Lin et al., 2013). This red-
activatable Channelrhodopsin (ReaChR), when expressed in
gustatory neurons, was used for the precise regulation of male
courtship song of freely moving adultDrosophila flies, to discover
a two neuronal-regulated command-like components (Inagaki
et al., 2014).
For more detailed focused reviews, refer to the following
reviews (Rein and Deussing, 2012; Tischer and Weiner, 2014;
Guru et al., 2015).
Other non-membranous optogenetic proteins shall be
described below, following presentation of a different approach
to rationally generate light-responding membrane receptors,
now based on the structural similarities between mammalian
light-sensing receptors (opsins) - GPCRs themselves - and other
GPCRs.
Light My Pathway
Direct Light-Activation of GPCRs
GPCRs, all 7 serpentine transmembrane receptors that take
a barrel-like conformation, are the largest family of receptors
in vertebrates. Controlling these receptors is therefore an
FIGURE 3 | Light-sensing ion pumps. (A) The photosensitive channelrhodopsin-2 (ChR2) and halorhodopsin (NpHR) ion channels expressed in neurons allow the
polarization of the cells by sodium (Na+) or chloride (Cl−) influx. (B) Using these light-activated rhodopsins, it has been possible to control the responses of animal
models to e.g., elicit defensive behaviors in mice (see text for details).
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important area of interest to understand cell communication.
The challenge was to generate receptors that are triggered
by light, but transduce predetermined signaling pathways. To
this end, Airan and collaborators rationally designed chimeric
receptors where they kept the extracellular and transmembrane
domains of the Gt-coupled bovine green-absorbing rhodopsin
and exchanged the intracellular loops—reponsible for G protein
coupling - to those of either Gq-coupled human alpha 1
(α1AR) or Gs-coupled hamster beta 1 (β2AR) adrenoceptors. The
resulting receptors, named optoXRs, proved able to activate the
expected intercellular pathway upon light activation: opto-α1AR
activated Gq-responsive adenylate cyclase and downstream cyclic
adenosine monophosphate (cAMP), while opto-β2AR activated
Gs-activation of phospholipase C led to the second messenger
inositol triphosphate (IP3) (Figure 4). These optoXRs only
triggered biased-intracellular cascades, showing that endogenous
modules can be incorporated into synthetic systems (Airan et al.,
2009).
Secondary Metabolites
Cyclic AMP (cAMP) is a common secondary metabolite
downstream GPCR activation, which transduces intracellular
signaling by activating kinases and ion channels. Therefore,
cAMP control is an important cell communication signaling
molecule. To date, two photo-activatable enzymes, one that
produces and one that degrades cAMP, have been reported.
The first is the microbial photoactivatable adenylyl cyclase
(bPAC) from Beggiatoa which was found to increase 300-fold
in cyclase activity (cAMP production) under 405 nm light,
as compared to its non-stimulated state, in E. coli, Xenopus
oocytes, and Drosophila neurons. In the latter it produced
efficient light-induced depolarization and behavioral changes
(Stierl et al., 2011). Light-inducible bPAC has also been used
to rescue the function of rodent sperm that lack endogenous
SACY (soluble adenylyl cyclase)—an essential cAMP-signaling
component required for motility and capacitation of sperm
(Jansen et al., 2015).
Degrading cAMP is as important as producing it for cell
signaling responses, a task that is achieved by phosphodiesterases.
With such aim, and with the use of in silico protein modeling,
Gasser and collaborators noticed a strong structural similarity
between the PDE domain of dimeric human phosphodiesterase
2A (PDE2A) and red-light responsive dimeric PhyB (see below)
of Deinococcus radiodurans. By superimposing PhyB to PDE2A,
they bioengineered a red-light-activating phosphodiesterase
(LAPD), a chimera that hydrolyses up-to 6-fold more
cAMP/cGMP upon light absorption in cell cultures or in
zebrafish embryos. PhyB’s photo-activated state can be reversed
by far-red light (∼700 nm), a feature that remains in LAPD. In
addition, this red-light-PDE2A uses endogenous biliverdin as
chromophore (Gasser et al., 2014), unlike PhyB which utilizes
phycocyanobilin (see below).
Since bPAC and LAPD are activated by different wavelengths
they can be used to fine-tune control of secondary metabolite
signaling both in vitro and in vivo.
Photosensing below the Surface:
Non-membranous Proteins
Abovementioned is that the discovery of optogenetic channels
provoked a search for other proteins that respond to light, here
are some of the best described.
Light oxygen voltage (LOV) is a small domain found in
the N- or C-termini of some proteins from plants, fungi and
some bacteria that responds to either of these three stimulations.
There are two subclasses: modular LOV and short LOV (sLOV)
(Crosson et al., 2003).
LOV domains were first identified in plant phototropins
(LOV1 and LOV2) but also found conjugated to some regulatory
proteins of circadian rhythms, phosphodiestrases, kinases,
ubiquitin ligases, and DNA-binding proteins (Crosson et al.,
2003). The first sLOVs identified were found in the YtvA
protein of Bacillus subtilis (Losi et al., 2002). Homology sequence
comparisons uncovered similar domains in proteins from
different chemotropic and autotrophic prokaryotes (Jentzsch
et al., 2009). Interestingly, the mechanism of action of LOV
domain is conserved in prokaryotic and eukaryotic organisms
(Jentzsch et al., 2009). LOV proteins have an important
role in plant growth, development, regulation of circadian
clock, stress response and adaptation, as well as in bacterial
phototropism and cell-cell attachment (Lokhandwala et al.,
2016).
FIGURE 4 | Controlling GPCR signaling by photoactivation. By interchanging the intracellular domains (loops) of the Gt-coupled bovine green-absorbing
rhodopsin receptor for either the Gq-coupled human alpha 1 adrenogenic receptor (α1AR) (red), or Gs-coupled hamster beta 1 adrenogenic receptor (β2AR) (violet), it
is possible to activate single downstream pathways upon light activation: opto-α1AR activates adenylate cyclase and cyclic adenosine monophosphate (cAMP)
production while opto-β2AR activates phospholipase C leads to increase inositol triphosphate (IP3).
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The LOV domains found in many species were hypothesized
to be responsible for sensing light, oxygen and/or voltage.
Eventually, the N-terminal region of the Arabidopsis’ nph1 was
shown to contain a ∼100 amino acid region highly conserved in
many other sensor proteins (Huala et al., 1997). The LOVdomain
of nph1 from oat (Avena sativa) (AsLOV) was subsequently
proven to be the photoactivatable domain of nph1 (Christie et al.,
1999). The molecular mechanism involves photon absorption
by a covalent bond between flavin cofactor (riboflavin, FMN or
FAD) and a conserved cysteine residue, which remains stable for
several seconds. This interaction leads to conformational changes
and unwinding (undocking) of the C-terminal (Jα) helix (Wu
et al., 2009).
In practice, LOV domains can be coupled to a protein of
interest, usually in proximity to signal or functional domains,
to conceal them by the folding structure of the LOV domain.
Upon irradiation, the Jα helix is undocked and the signal or
functional region exposed (Lokhandwala et al., 2016; Figure 5A).
Combining a LOV domain adjacent to a localisation signal results
in cytoplasmic localization, which upon light activation exposes
the localization signal triggering re-localization (Yumerefendi
et al., 2016). Several variants of this technique exist, such as
LEXY, LINuS, LANS or LINX which consist of the concealment
of nuclear export (NES) or/and nuclear localization (NLS) signals
by LOV2, respectively (Niopek et al., 2014, 2016; Di Ventura and
Kuhlman, 2016;Wehler et al., 2016; Yumerefendi et al., 2016). All
of these modifications are short and genetically encoded domains
that can be joined at the C- or N- terminus of proteins of interest
(Wehler et al., 2016).
Beyond protein re-localization, although important as
described above, the LOV domain has been adapted to the
regulation of protein complexes, as well as the activity of
enzymes. Here, there are some outstanding examples of these:
TULIPs (tuneable, light-controlled interacting protein tags)
are two protein interaction systems based on the AsLOV2
synthetic domain caging a peptide epitope and, separately, its
binding partner—a variant of the Erbin PDZ domain (ePDZ)
(Strickland et al., 2012). PDZ domains mediate protein-protein
interactions by binding to the C-terminus of their target protein,
in a sequence-specific manner. The name PDZ is an acronym of
the first three proteins in which these domains were discovered:
PSD-95, DLG, and ZO-1 (Kennedy, 1995).
An engineered ePDZ domain, characterized for high-affinity
and high-specificity to a peptide epitope (–SSADTWV–COOH)
was selected (Skelton et al., 2003; Huang et al., 2009), while the
peptide epitope was inserted into a truncated Jα helix C-terminal
(called LOVpep) that had the lowest background activity—no
binding to ePDZ in dark. After light induction, and Jα undocking,
this additional peptide was rapidly bound by ePDZ domain,
bringing the two proteins together.
By fusing GFP-LOVpep with transmembrane protein Mid2,
thereby cell membrane localisation, the system was tested for
its ability to recruit ePDZ-mCherry from cytoplasm to cell
periphery. Most of the ePDZ-mCherry fusion was diffusely
present in the cytoplasm in dark. After light excitation (473
nm), ePDZ-mCherry quickly colocalised with GFP-LOVpep
at the cell membrane of yeast (Strickland et al., 2012).
LOVpep/ePDZ dimerization has been also shown to operate
in HeLa cells by either cell membrane or mitochondria
colocalisation. Translocation is reversible even after 3 cycles of
light excitation/recovery.
In yeast, mating behavior begins upon pheromone stimulation
of a GPCR, which triggers two intracellular pathways: the MAPK
pathway and the GTPase Cdc24 cascade. MAPK signaling leads
to G1 arrest, and in consequence, growth inhibition, and is
initiated by the recruitment of scaffold protein Ste5 and other
components, such as Ste11, to the activated G protein. It is
known that tethering Ste5 or Ste11 to the cell membrane
activates the MAPK pathway (Winters et al., 2005). The Cdc24
cascade is required for polarized growth. The investigators
then designed a TULIP for optical control of either MAPK or
FIGURE 5 | Structure and function of LOV. (A) The light/oxygen/voltage
(LOV) domain is composed by a “core” and a helical domain called the Ja
helix. Together they sandwich a flavin molecule in dark conditions. Upon light
activation the Ja helix undocks. The LOV domain has been harnessed to cage
signal peptides or functional domains of enzymes. (B) Organelle transport by
LOV (mitochondria). A mitochondria-localized LOV domain caging a small
peptide (LOVpep) that upon light exposure is exposed and bound by an
engineered PDZ domain (ePDZ). By fusing ePDZ with motor protein kinesin, it
is possible to control the translocation of mitochondria along microtubules in
the axons of neurons. (C) Light-control on migration: In dark the LOV domain
sterically blocks a constitutively-active Rac1. Uncaging Ja helix by light
exposes Rac1 to its effector protein, triggering actin filament polymerisation
and stimulated cell movement in the direction of the cell’s illuminated edge.
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Cdc24 activation in budding yeast, without the involvement
of G proteins or GPCRs by light-activation of the recruitment
of ePDZ-Ste5delN (an allele deficient in G protein binding)
or ePDZ-Ste11 (for MAPK activation), and Cdc24–ePDZb1
fusions to the membrane (Mid2-LOVpep, as above). As expected,
all constructs showed no detectable dark-state changes, while
growth arrest and/or polarization occurred upon continuous
light excitation (Strickland et al., 2012). These results confirmed
that this system can be successfully utilized for various purposes,
including intracellular signaling.
van Bergeijk and colleagues used LOVpep not only to
control protein movement but control organelle transport and
positioning. Peroxisomes were labeled with LOVpep, fused
to the peroxisome localization signal of PEX3. While ePDZ
was fused with Kinesin-3, a plus-motor protein which moves
along microtubules. Using monkey COS-7 cells as a model, the
authors showed that blue irradiation triggered the translocation
of peroxisomes from the cells’ center to periphery, where
most plus-microtubules are found. Furthermore, as the “cherry
(not the fluorescent protein but the fruit of Cerasus spp) on
the cake,” mitochondria-tagged by LOVpep, via mitochondrial
membrane protein TOM20, were either translocated or anchored
via microtubules along the axons of neurons, using ePDZ fused
to Kinesin or SNPH, respectively (van Bergeijk et al., 2015;
Figure 5B).
In another remarkable study, Wu et al. demonstrated that
it is feasible to direct cell motility using LOV. They fused
the LOV domain to the constitutively-active GTPase Rac1
(∗Rac1), a regulator of actin cytoskeletal dynamics, and thus cell
migration. In dark, the LOV domain sterically blocks ∗Rac1,
uncaging Ja helix by light leads disinhibition of ∗Rac1, to
bind its effector protein and polymerise actin filaments. This
reversible mechanism was sufficient to create cell movement in
the direction of light (Wu et al., 2009; Figure 5C).
Some of the systems described above could be considered
molecular machines, as the definition for these is “an assembly
of a distinct number of molecular components that are designed
to perform machinelike movements (output) as a result of
an appropriate external stimulation (input)” (Balzani et al.,
2000). Most molecular machines combine synthetic with natural
molecules to achieve certain activity e.g., movement. Until now,
virtually all molecular machines have been tested using purified
molecules under carefully controlled environments. An example
of this: kinesin molecules used as nanocarriers as they move
along purified microtubules attached to a surface (Bachand et al.,
2005; Furuta et al., 2017). Molecular machines have the potential
to harness the cells’ metabolism as fuel, while driving pre-
determined cellular activities. We refer the reader to specialized
reviews on this subject (Balzani et al., 2000; Collin et al., 2001;
Wesley and Browne, 2006; Feringa, 2007; Cheng and Stoddart,
2016).
Photo-Finish: Light-Induced Dissociation
In all LOV stories (above), the storyline has been along the final
union of two protein complexes and their cargoes. Yet, LOV
has a dark side too, something that has recently given rise to
LOVTRAP. LOVTRAP builds on the LOV2 domain anchored
to the mitochondrial membrane, and the Zdk domain—a
genetically engineered Z domain of bacterial protein A which has
high affinity to the dark state of LOV2. Therefore, attaching Zdk
to a POI results in colocalisation with mito-LOV2 (LOVTRAP).
Cyan-light induces LOVTRAP to release Zdk-POI, a 150-fold
change in the dissociation constant, to the cytosol, in a reversible
manner. LOVTRAP has been successfully used to fine-tune
the sequestration and release of several cytoplasmic proteins
(GTP exchange factor Vav2, GTPase Rac1, and PI3K kinase) in
mammalian cells, actions that modulated the activity of these
proteins without any influence from endogenous regulatory
pathways (Wang et al., 2016).
Another photo-dissociating protein is Dronpa, a green
florescence that changes conformation from tetrameric to
monomeric, and back, depending on the wavelength of light
excitation. Dronpa owes its name to “dron,” a ninja term for
“vanishing,” and “pa” referring to photoactivation. The dronpa
gene was discovered during a screening of cDNAs from stony
coral Pectiniidae sp. (Ando et al., 2004). Dronpa protein may
occur in two stages: ON as a bright green tetramer, or OFF
as a dark monomer under cyan light (∼500 nm) excitation.
Furthermore, violet light (∼400 nm) is able to restore tetrameric
formation (Ando et al., 2004; Zhang and Cui, 2015). Note:
a rationally designed dimeric Dronpa has been developed by
site-directed mutagenesis (Zhou et al., 2012). These ON/OFF
properties of Dronpa have been successfully used in vivo in
zebrafish to visualize single neurons inside tissues. For this
purpose, temporal neuronal-specific expression of Dronpa was
achieved by mRNA transfer. Then, time-lapse imaging was
performed by erasing the Dronpa fluorescence entirely, and
re-highlighting it in a single neuron by violet-light. This
procedure was repeated several times in order to reconstruct the
entire neural network of zebrafish (Aramaki and Hatta, 2006).
Besides Dronpa’s light-switchable states, it has also been used
to disaggregate proteins, mostly from a caged conformation—
two Dronpa molecules flanking a functional domain. Dimeric
or tetrameric Dronpa, upon cyan-light, dissociate, exposing the
caged domain. For example, ITSN2 (Intersectin 2, Cdc42-specific
mediated by guanine nucleotide exchange factor GEF) was fused
to a Dronpa at each end. One of the Dronpa moieties had a
membrane localization signal (CaaX). ITSN2, which normally
activates Rho family GTPases—the master regulators of the actin
cytoskeleton—, and is associated with centrosomes (Yeh et al.,
2007; Rodriguez-Fraticelli et al., 2010), was inactivated by two
flanking Dronpa caging. Upon cyan-light, Dronpa dissociated
exposing the ITSN2 functional domain, prompting the formation
of abundant filopodia within 30 min from illumination (Zhou
et al., 2012; Figure 6). The same approach was used to generate
a Dronpa-caged hepatitis C virus NS3-4A protease. Upon blue-
light activation, protease activity was measured by the release
of a mCherry-ss-CaaX from the cell membrane by cleaving its
substrate site (ss) (Zhou et al., 2012).
Parting for a New Partner
UV-resistance locus 8 (UVR8) is an Arabidopsis photoreceptor
protein. This protein forms homodimers that are photolabile and
thus dissociate upon ultra-violet light (UVB) exposition (ChenD.
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FIGURE 6 | Photo-de-dimerization. Dronpa protein can occur in two reversible stages: ON as a bright green tetramer (or a engineered dimer), or OFF as a
non-fluorescent monomer under cyan light (405–450 nm), and back to ON stage after UV light excitation (390 nm). Light-induced dissociation used to control the
activity of ITSN, a Rho GTPases regulator. The caged conformation—a Dronpa-ITSN-Dronpa targeted to the membrane via CaaX motif forming a tetramer. Cyan-light
induces tetrameric dissociation unblocking ITSN active site and the formation of fillopodia. The process can be reversed by UV light.
et al., 2013). Photon absorption leads to conformational changes,
which remain for several hours (Christie et al., 2012; Wu et al.,
2012). After dissociation, monomers reversibly bind to partner
COP1 (constitutively morphogenic 1) protein (Kim and Lin,
2013).
UVR8 has been mainly used to regulate transcriptional
activation, where a DNA-binding domain fused to COP1
e.g., GAL4 DNA-binding domain-COP1, binds to a specific
promoter, yet transcriptional activation is achieved by binding of
photoconverted UVR8 fused to a transcriptional activator, such
as NF-κB transcription domain—which causes a linear induction
of a gene expression in mammalian cells (Crefcoeur et al., 2013).
The first light-triggered protein secretion method was
developed using UVR8 protein properties. UVR8 was fused with
C-terminal domain of well-documented secretory trafficking
marker VSVG (vesicular stomatitis virus glycoprotein) and
tagged with a fluorescent protein (FP). UVR8-VSVG-FP formed
homodimers that were sequestered at the endoplasmic reticulum
until photoactivation caused robust forward trafficking to the
cellular membrane through the secretory pathway in neurons
(Chen D. et al., 2013). This allowed the visualization of
cellular markers and secreted cargo as it traverses the secretory
pathway. Moreover, it circumvents the requirements of other
tuneable secretion systems such as temperature changes or
chemical-induction. An advantageous additional feature is
that tryptophan-rich UVR8 domain requires no cofactor for
photoreaction (Zhang and Cui, 2015), although exposure to UV
light is a cause of concern, due to cellular and genetic damaging
effects.
Finding a Partner When Illuminated
The HY4 gene of Arabidopsis thaliana, encoding a protein with
characteristics of a blue-light photoreceptor, was first described
by Margaret Ahmad and Anthony R. Cashmore in 1993 (Ahmad
and Cashmore, 1993). CRY2 (blue-light receptor cryptochrome
2), product of HY4, is a member of photolyase-like blue-
light receptors which mediates light responses in plants (Liu
et al., 2008). CRY2 is the best characterized photosensor in
Arabidopsis, where upon light activation physically interacts
with, and activates, the transcription factor Cryptochrome-
Interacting Basic helix–loop–helix 1 (CIB1) (Liu et al., 2011), an
interaction that is reversed in absence of blue-light (Liu et al.,
2013).
The CRY2/CIB1 interaction was initially tested in mammalian
cells by re-localizing proteins to the plasma membrane: CIB1
was fused with GFP and the CaaX prenylation motif for plasma
membrane localization, whilst CRY2was fused tomCherry. Blue-
light resulted in the recruitment of CRY2-mCherry from the
cytoplasm to the cell membrane of transfected HEK293 cells
within seconds (Figure 7A). In the same work, the authors
described the creation of a split CRE recombinase (see Box 3)
that can form a functional enzyme when the two complementary
halves are united by CRY2/CIB1 under blue-light inHEK293 cells
(Kennedy et al., 2010).
In a different work, researchers showed that the CRY2/CIB1
could be used to photo-manipulate transport vesicles inside
cells by fusing CIB1 to Rab GTPase, a protein that binds to
vesicle membranes, and co-expressed with CRY2-YFP in cells.
In darkness, vesicle transport behaved normally, and CRY2-YFP
was found freely diffusing in the cytoplasm. Blue-light activation
resulted in the aggregation of CRY2-CIB1-Rab GTPase, as
photoexcited-CRY2 not only binds to CIB1 but also becomes
attracted to each other (Figure 7B). Such clumps disrupt vesicular
transport, suspending it until blue-light is turned off. In this
way, the functions of specific Rab proteins in vesicular transport
could be studied in neurons (Nguyen et al., 2016; Figure 7C).
Rab GTPases mediate processes such as receptor transport,
protein sorting, endocytosis, and protein secretion, thus using
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FIGURE 7 | Non-membranous opto-dimerisers. (A) Dimerization by light. There are several available light-activated dimerisers such as CRY2 and CIB1 (others are
portrayed too, see Figure 8). Heterodimerisation allows the coupling of complementary fragments or separated proteins upon photo-illumination. (B) Vesicle control
by CRY2/CIB1. Different Rab GTPases, a family of proteins that bind to different membranes, were fused to CIB1 and co-expressed in cells with CRY2-YFP. In
darkness, vesicle transport behaved normally, and CRY2 was found freely diffusing in the cell. Blue-light activation resulted in the aggregation of CRY2/CIB1-Rab
GTPase as photoactivated-(pa)CRY2 not only binds to CIB1 but is also attracted to other paCRY2. (C) Control of vesicle-dependent processes. Rab GTPases
mediate processes such as receptor transport, protein sorting, endocytosis, and protein secretion, thus using CIB1-Rab GTPase/CRY2-YFP it is possible to control
such processes dependant on the chosen Rab GTPase.
this method it is possible to control such processes, depending
on the chosen Rab GTPase.
Since 2016, a second-generation CRY2/CIB1, having smaller
proteins with reduced association in darkness and improved
signaling states upon blue-light stimulation, is available (Taslimi
et al., 2016). Yet, the conformation between CRY2 and CIB1
may prevent the interaction of cargo proteins. For example,
Nihongaki and co-workers attempted to create a photoactivatable
CRISPR/Cas9 using these partners carrying complementary
halves of Cas9. However, that yielded no functional Cas9 and thus
the authors chose a different pair of dimerising proteins, called
magnets (see below).
Phytochromes B (PhyB) are chromoproteins naturally
occurring in cyanobacteria and plants. PhyB binds to
chromophore phycocyanobilin (PCB) as a cofactor that
functions as a red-light sensor. Upon red-light exposure (∼660
nm), PCB induces a conformational change in PhyB leading to
its active form, PhyBFR. This form interacts with Phytochrome
Interacting Factor (PIF), an interaction that can be reversed with
even further far-red light (∼740 nm; Ni et al., 1999; Kim and
Lin, 2013). The Phy/PIF system has been used in mammalian
cells to control the actin cytoskeleton where PIF was fused to
a constitutively active ∗Rac1 and this moiety was recruited to
specific edges of the cell by photoactivating a PhyB tethered to
the cell membrane. The result was the formation of protrusions
(filopodia) from cell edges exposed to red-light (Levskaya, 2009),
similar to the morphological changes to the LOV-Rac1 example
described above.
Recently, the PhyB/PIF pair has been optimized for zebrafish
by delivering a novel engineered PCB into embryos along with an
optimized PhyB/PIF pair. Upon red-light exposure, membrane
localized, PhyB-CaaX rapidly recruited PIF. Additionally,
shifting the light to 750 nm released PIF back to the cytoplasm.
To test whether the polarity of protein distribution could be
manipulated at specific subcellular regions in living embryos,
the authors generated a Pard3 (apical polarity protein 3)-PIF6
fusion protein, which could be directed by light to its binding
partner, Pard6-PhyB-CaaX, at illuminated cell-to-cell joins,
causing changes of polarity during neural tube development
(Buckley et al., 2016).
One advantage of PhyB/PIF is its excitation wavelength,
which is ideal for in vivo applications. Unfortunately, PhyB’s
chromophore, PCB, is absent in animal cells and thus should be
exogenously supplemented which is a minor deterrent in vitro
but a serious limitation in vivo.
The different wavelengths required for activation of
optogenetic proteins makes feasible multi-chromatic inducible
operations, as was achieved and reported by Müller et al. (2013)
exploiting already existent optogenetic proteins. This was proved
in single cells carrying three different gene reporter constructs
and three different optogenetic dimerising proteins fused to
transcriptional activators. These were: (1) a 311 nmUVR8/COP1
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pair, where UVR8 was fused to macrolide-responsive repressor
E, that binds near a minimal human cytomegalovirus promoter
PhCMVmin, and COP1 fused to transcriptional activator
V16 (Müller et al., 2013); (2) a Gal4-LOV-p65 (the activation
domain of NF-κB transcription factor) which upon 465 nm
light homodimerises and binds to the CMV promoter (Wang
et al., 2012); and (3) a 660 nm PIF-TetR, a protein recognizing
the TetO operator, and PhyB-V16 (Chen X. et al., 2013). Each
of these constructs only induced specific gene expression
(PhCMVmin-angiopoietin, CMV-vascular endothelial growth
factor and TetO-firefly luciferase, respectively), in response to
the correct wavelength, in a single cell (Müller et al., 2013).
Despite these impressive results, optogenetic techniques
have limitations: they leak at different degrees in dark,
heterodimerision might occur when the unstimulated proteins
are overexpressed, and, in the case of protein dissociation,
the two subunits must be at virtually identical levels, or the
trapping one in excess, so there is no free active-subunit. Major
challenges remain for the optimization of LOV-caged protein
activity with no universal solution for them (Wu et al., 2009).
Another disadvantage of the blue-to-orange excitation spectra
is that they do not penetrate animal tissues as well as red-light
(Jacques, 2013) which reduces their applications in vivo. Figure 8
summarizes several optogenetic actuators in relation to their
activation wavelengths and characteristics.
The majority of somatic cells experience mechanical forces,
namely pressure, flow, stretching, etc, during their existence.
Cells respond to such mechanical forces in multiple ways
but ultimately change their phenotypes and cellular activities.
Therefore, mimicking physiological conditions is essential to
understand cellular activities.
LET THE FORCE BE WITH YOU:
REGULATION OF
MECHANOTRANSDUCTION
A variety of methods, exist to analyse cellular responses to
mechanotransduction. Noting that physical stimulation of cells is
characterized by a low efficiency (Liu et al., 2016). Experimental
strategies to induce mechanical stress include: fluid shear stress,
where cells are exposed to changes in the perfusion and/or
viscosity of fluids, and cell stretching—where the adhesion
surface is stretched. Although, the advantage of these techniques
is a very precise regulation of cell morphology, and the possibility
of coupling these systems to high-resolution microscopy, the
manipulation of specific mechanoreceptors at the molecular level
is not possible.
To address this issue, functionalized magnetic nanoparticles
(fMNPs) have been engineered to bind specific cellular
mechanoreceptors, after which, using magnets, the fMNPs can
be pulled into any given direction to trigger mechanoreceptor
signaling (Etoc et al., 2013). In this manner, concrete
mechanoreceptors can be specifically activated for downstream
applications. It has been reported that fMNPs coated with Rho-
GTPases, regulators of actin cytoskeleton, can be magnetically
localized to one of the cell’s edge, leading to local remodeling
of the actin cytoskeleton and morphological changes in various
cell lines (Etoc et al., 2013). Although this procedure is highly
specific, it lacks spatial resolution in particular in vivo.
By combining nano- and photo-sensing technologies, the
optomechanical actuator (OMA) was generated. OMA consists
of gold nanorods coated with a thermoresponsive polymer
which shrinks immediately upon near-infrared illumination,
thereby applying a mechanical load to e.g., a membrane
receptor attached to an immobilized ligand. Thus, allowing
manipulation of receptor mechanics with high spatio-temporal
resolution. This method exploits optomechanical actuation of
transmembrane receptors that are involved in cell-cell and cell-
matrix interactions. These optomechanically activated receptors
triggered the local recruitment of the focal adhesion markers:
paxillin, F-actin and vinculin which allow the precise control of
focal adhesion formation, cell protrusions, cell migration and
T cell activation, through the application of cyclic mechanical
stimulation induced first by near-infrared illumination. OMA
can also be used in combination with protein ligand receptors
(Liu et al., 2016).
In all cases, mechano- or magnetic-stimulation involve
specialized equipment and thus not commonly used (Liu et al.,
2016). Moreover, these techniques are mainly focus on the
engineering of chambers and/or functionalized nanomaterials,
which are then used to study simple cultures or single cells. We
refer to reader to a couple of specialized reviews on the subject
(Humphrey et al., 2014; Iskratsch et al., 2014). fMNPs could be
used in vivo under controlled conditions though.
A very elegant approach has been the adaptation of the
Notch signaling concept. The Notch signaling pathway is
an evolutionarily conserved cell communication mechanism
present in most multicellular organisms. This pathway plays
essential roles during cell fate determination in both during
development and tissue homeostasis. The Notch pathway
functions via mechanoactivation by any of Notch ligands (DLLs
or JAGs) on the signaling (aka sender or sending) cell, which
binds and activates the Notch receptor on the neighboring
cell—the receiving (aka receiver) cell. This interaction results
in conformational changes in Notch extracellular domain and
the exposure of a cryptic region that is then proteolyticaly
cleaved by disintegrin, ADAM metalloproteinase and finally,
intracellularly, by gamma-secretase. The result is the release
of Notch intracellular domain (NICD) which then translocates
to the nucleus to function, together with a complex of
other proteins, as a transcriptional activator (TA) (Kopan,
2002).
Instead of being limited to Notch receptors and Notch ligands,
Morsut and collaborators engineered a series of constructs, called
synthetic Notch (synNotch), where the extracellular domain of
Notch was replaced by monoclonal antibodies, fused to the
transmembrane domain (TMD) of Notch, followed by different
transcription factors at the intracellular domain. As in Notch
activation, the mechanical forces between the antibody and the
surface-attached antigen resulted in the exposure of the cryptic
region and the release of the intracellular domain (transcription
factor). SynNotch was tested using a variety of transcription
factors on cells that only upon presentation of the correct antigen,
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FIGURE 8 | A guide to some of the most commonly used optogenetic systems to-date. Scheme of properties and conformational changes of several
photoactivatable systems [phytochrome B (PhyB-PIF), red-light activatable phosphodiesterase (LAPD), Chrimson, Halorhodopsin (NpHR), Channelrhodopsin-2
(ChR2), LOV domain, adenylyl cyclase (bPAC), Dronpa and UV-resistance locus 8 (UVR8-COP1)]. Individual light-induced proteins have been assigned to their
activation wavelength. Each system is shown before light stimulation (left) and after irradiation (right). Necessary cofactors are marked. Simultaneously this diagram
shows the characteristics of different wavelengths on cell structures as well as tissue penetration. The detailed description of all these proteins can be found in the text
this article. The image is partially based on (Zhang and Cui, 2015) and examples within the text.
immobilized or presented by another cell, translocated to the
nucleus and transactivated a reporter gene (Morsut et al., 2016;
Figure 9). The flexibility of this system allows the generation of
circuits and/or cell communication networks e.g., activation of
one synNotch in a cell induced the expression of a membrane-
bound specific antigen which in turn activated the neighboring
cell(s) expressing the synNotch for this consecutive antigen. By
this means, the authors created a multi-layered cell cascade using
epithelial cells (Morsut et al., 2016).
Since the extracellular domain (antibody), ligand (antigen)
and intracellular domain (transcription factor) are exchangeable,
multi- and orthogonal-signaling are possible. The only limitation
of this technique is the need for surface-attached ligand(s), in
other words, an artificial environment needs to be generated
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FIGURE 9 | SynNotch system. Activation of Notch by its ligand (DLL) leads to mechanical forces and further proteolytical (scissors) cleavage of Notch extracellular
domain (NICD) which then translocates to the nucleus and modulates gene expression. SynNotch exploits the mechanism of Notch receptor activation, using an
antibody as an extracellular domain fused to the transmembrane domain (TMD) of Notch. Instead of NICD, different transcription factors can be used. The mechanical
forces between the receptor (antibody) and the cell- or surface-attached ligand (antigen) resulted in the release of the intracellular domain (transcription factor) and the
transcription of specific genes (reporters).
which obviously limits in vivo applications. Yet, it can be
used to unravel many other important biological questions,
and pave the way for more complex synthetic circuits
in mammalian cells which is needed for proper tissue
engineering.
BACK TO BASES: GENOMIC CONTROL
The modification of cellular behavior cannot be completed
without the ability to modify the cell’s genome and epigenome.
As expected, the obvious design to modify the genome was
by use of site-specific nucleases, although it was the advent
of RNA-guided nucleases that has revolutionized the field
completely.
Traditionally, gene control has been achieved by the use of
vectors that carry genes under constitutive promoters. This view
has gradually been replaced for tools that are able to erase,
edit, or turn on or off endogenous genes. Genome editing,
the availability to rewrite the information in the genome, is
undergoing a craze due to a series of new and innovative
methods that have made gene editing possible by virtually
any lab.
The crucial breakthrough in genome editing was
domestication of several naturally occurring DNA-binding
proteins, and then their genetic modification, which lead to
their sequence-specificity. Firstly, meganucleases, restriction
endonucleases with long (14–40 bp) recognition sites, were
meticulously mutated to recognize and cut desired sequences
(Grizot et al., 2009). Yet, this is labor-intensive and the new
restriction sites do not differ significantly from the original,
further they might be promiscuous to their recognition
sequences.
Instead of designing nucleases that recognize and cut DNA
within the same domain, DNA-binding domains from different
proteins could be used for sequence specificity, and then fused
to a nonspecific nuclease. On this view, polydactyl zinc-fingers
(ZFs) (Maeder et al., 2009; Gonzalez et al., 2010) were created.
ZFs are domains found in transcription factors, DNA- and
RNA-binding proteins that recognize a triplet of nucleotides.
Thus, combining different ZFs, sequence-specific domains can
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be created. Due to their modular properties, and since they do
not have nuclease activity on their own, ZFs were fused to the
nuclease domain of the FokI restriction endonuclease and named
ZF nucleases (ZFNs) (Kim et al., 1996). Locus specificity of ZFNs
is determined by the ZFs, while. FokI, which needs to work as
a dimer to cut DNA, functions as genetic scissors—two adjacent
ZFNs, on opposite strands of DNA, are required to cause double
strand brakes (DSB) (Urnov et al., 2010). Nevertheless, ZFNs
have several limitations as there is no ZF modules for each of the
64 possible triplets.
In 2009, two independent groups reported the decoding
of the Transcription Activator Like Effectors (TALEs) (Boch
et al., 2009; Moscou and Bogdanove, 2009), natural type III
effector proteins secreted by numerous species of the plat
parasites Xanthomonas spp. These proteins modulate gene
expression in host plants to facilitate bacterial colonization and
survival. TALEs are beautiful modular proteins, each module
identical to the others but in two residues (variable di-residues)
(LTPEQVVAIASxxGGKQALETVQRLLPVLCQAHG) and each
module binds to a single nucleotide in genomic DNA. In
Xanthomonas there is an additional transcriptional activator (TA)
attached to the C-termini of these proteins. Following ZFNs,
TALEs have been fused to Fok1 to cut specific DNA sequences—
called TALE nucleases or TALENs (Miller et al., 2011; Mussolino
et al., 2011; Mussolino and Cathomen, 2012).
TALEs have not only been used as nucleases but also, as in
the original Xanthomonas scheme, fused with a transcriptional
activator (TA) e.g., TBP (TATA-binding protein) (Anthony et al.,
2014) or a transcriptional repressor (TR). Since TALEs bind
specific regions of DNA without affecting it, they have also been
coupled to optogenetic proteins for the activation or repression
of gene expression, and named Light-Inducible Transcriptional
Effectors (LITEs). LITEs modulate gene expression by virtue of
two components: TALE-CRY2 which is designed to recognize
a target locus (see below) and CIB1 linked to either a TA e.g.,
VP64, or a TR e.g., KRAB or p300core. TALE-CRY2 binds to
DNA and upon blue light dimerises to CIB1-TA or CIB1-TR
to induce activation or silencing of gene expression, respectively
(Konermann et al., 2013; Figure 10E).
The advantage of TALEs and LITEs are their pliability, as
many other genomic editors can be placed to study genetics
and epigenetics (see below). Although, TALEs are genetically
constructed by assembling almost identical modules, there are
several excellent methods to facilitate their cloning, such as
Golden Gate and LIC (Cermak et al., 2011; Schmid-Burgk et al.,
2013). Addgene maintains an up-to-date list of techniques and
TALE plasmid kits at https://www.addgene.org/talen/.
A better modular design could hardly be envisioned, but then
however the type II CRISPR systems, which stands for Clustered
Regularly Interspaced Short Palindromic Repeats, began to be
understood (Mojica et al., 2009). Unlike previous designed-
nucleases, type II CRISPRs combine RNA and protein—a
nuclease—to target specific sequences of DNA, or RNA (see
below).
CRISPR are the adaptive immune system of prokaryotes
(bacteria and archae) and involve RNA-activatable nucleases.
The activating RNA(s), sometimes one and sometimes two,
guide the nuclease to the nucleic target, in most cases DNA.
The components of CRISPR have been discovered in parts and
has been enigmatic until recently. The first full description
of CRISPR/Cas9 from Streptococcus pyogenes and Streptococcus
thermophiles was achieved by two independent groups (Gasiunas
et al., 2012; Jinek et al., 2012). They found that CRISPR/Cas9
required two RNAs to be able to target DNA. One of the
RNAs, called CRISPR-related RNA (crRNA) encodes the target
in its 5′ terminal, while the rest is partially complementary to
a second RNA, the transactivator of crRNA (tracrRNA). The
crRNA-tracrRNA complex is recognized by Cas9 and together
they find the complementarymatch to the 5′ region of the crRNA.
The target, an invading phage’s DNA, should have a
complementary sequence to the crRNA 5′ end, followed by
a protospacer adjacent motif (PAM), a short sequence that is
not present in the crRNA (and thus absent in the prokaryote’s
genome) as a safeguarding element to avoid self-immunity.
CRISPR is, to date, considered the simplest and most efficient
editors of (epi)genomes, since it involves no protein engineering
(Sander and Joung, 2014; Barakate and Stephens, 2016). One of
the most favorable features of these nucleoproteins complexes
is that they unite all the components of the molecular biology
central dogma (DNA-RNA-protein). This is virtually exclusive to
them and thus many of the applications we will mention below
are possible thanks to this fact.
Furthermore, CRISPR/Cas9 has been simplified by linking the
two types of RNA into one single-chain guide RNA (gRNA, aka
single guide RNA or sgRNA) (Jinek et al., 2012; Wang and Qi,
2016), and later on, adapted to gene editing in mammalian cells
by Feng Zhang’s and George Church’s labs (Cong et al., 2013; Mali
et al., 2013; Figure 10A).
Other simplifications involve (1) the co-expression of Cas9
and the gRNA from a single plasmid, the gRNA being expressed
under a pol III promoter such as U3, U6 or H1, while Cas9
under the universal CMV promoter (Cong et al., 2013); (2) The
expression of multiple gRNAs from a single transcript by use of
either Csy4 endoribonuclease (Box 1) (Nissim et al., 2014; Tsai
et al., 2014) or ribozymes—self-cleaving RNA domains (Box 2),
or a highly conserved tRNA-processing mechanism—where
endogenous RNases remove extraneous 5′ and 3′ sequences from
the tRNA precursors (Carter and Wolfenden, 2015; Xie et al.,
2015; Qi et al., 2016). Why multiple gRNAs? First because an
increased number of targeting gRNAs enhanced mutagenesis
efficiency in rice and maize (Xie et al., 2015; Qi et al., 2016), and
second, because this allows multigene targeting (Li et al., 2013;
Wang et al., 2013; Niu et al., 2014).
As pol III promoters cannot provide tissue-specificity
expression of gRNAs, producing multiple gRNAs has been
made possible by incorporating gRNAs into the 3′UTR of Cas9
mRNA—regulated by a pol II promoter, and flanking them with
ribozymes (Yoshioka et al., 2015; Xu L. et al., 2016), or Csy4
recognition sites (Box 1; Tsai et al., 2014).
CRISPR/Cas9 has already demonstrated its effectiveness
to modify endogenous genes of various bacterial, plant or
animal organisms, and currently there is the first human
clinical trial (https://clinicaltrials.gov/ct2/show/NCT02793856?
term=crispr&rank=4). In addition, it should be noted that gRNA
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FIGURE 10 | Gene targeting. (A) CRISPR/Cas9 is based on Cas9 endonuclease and its guide RNA (gRNA = crRNA and tracrRNA synthetic fusion). The 5′ end of
the gRNA contains a sequence complementary to the target. Cas9/gRNA complex binds and cleaves specific DNA sequence only if followed by a PAM motive (NGG).
(B) CRISPRi system utilizes fusion of dCas9, and DNA-binding domain (DBD), to a protein known to recruit repressive chromatin-modifying complexes, such as the
Kruppel associated box protein (KRAB), which induces H3K9 methylation, resulting in virtually complete gene repression. (C) CRISPRa is used for gene transcriptional
activation. dCas9 was fused to a transcriptional activator (TA) such as VP64 or VP128. (D) paCRISPR (photoactivatable CRISPR) utilizes photo-dimerising proteins
called Magnets (positive—pMag and negative—nMag). Upon light activation, the split fragments of Cas9 [Cas9–N713 (residues 2-713) and C714 (residues
714-1,368)] are united to form a fully functional Cas9, i.e., a paCRISPR-TA for controlled transcriptional activation depicted. (E) LITE system enables modulating of
gene expression by virtue of two components: TALE-CRY2, as a DBD, and CIB1 linked to either a TA e.g., VP64, or a transcriptional repressors (TR) e.g., KRAB.
Upon blue-light TALE-CRY2, bound to DNA, dimerises to CIB1-TA or CIB1-TR inducing activation or silencing of gene expression, respectively.
BOX 1 | CSY4.
Csy4 protein, first described in Pseudomonas aeruginosa and Pectobacterium atrosepticum, is an RNA endoribonuclease that processes CRISPR transcripts
(pre-crRNAs) (Haurwitz et al., 2010; Przybilski et al., 2011). Csy4 recognizes a 28 bp spacer sequence (GUUCACUGCCGUAUAGGCAGcuaagaaa), where the last 8
nts can be variable (Tsai et al., 2014), on pre-crRNAs and cleaves immediately after the 20th nucleotide (Haurwitz et al., 2010, 2012; Sternberg et al., 2012). Due to
the fact that Cys4 remains bound to the cleaved RNA, this enzyme can be used to cleave as well and binding RNA.
Csy4 has been used for producing gRNAs encoded in the 3’UTR mRNA of other genes expressed under the CMV promoter. One, or several gRNA is flanked by
two Csy4 binding sites. Double cleavage by Csy4 releases the functional gRNA for further activation of CRISPR/Cas9 targeting of genomic loci. These tools were
used for efficient modulation of endogenous promoters and implementation of tuneable synthetic circuits, including multi-stage cascades and RNA-dependent
networks (Bikard and Marraffini, 2013). Csy4-based multiple gRNA generation for CRISPR applications has been applied in zebrafish, where several genes were
simultaneously knocked out (Qin et al., 2015).
BOX 2 | RNA SELFIES.
Ribozymes are RNA molecules that can perform enzymatic reactions, usually self-cleaving. Due to this feature, they have been used to cleave mRNA in bacteria and
eukaryotes. The finding that some ribozymes can be inhibited by small molecules like theophylline toyocamycin (Thompson et al., 2002; Yen et al., 2004; Kim et al.,
2005) allows the control of such riboswitches (Figure 12A). Interestingly, photo-caged derivatives of toyocamycin exist, and they have been used for photochemical
modulation of the protein expression in mammalian cells (Young et al., 2009).
Since ribozymes cleave RNA unaided, they have been used to excise gRNAs from the 3’UTR of reporter genes or even of Cas9 to assure expression of both as well
as to generate multiple gRNAs from a single transcript (see main text for details).
The use of nucleoside analogs (as toyocamycin) into cells causes significant side effects. Thus, the development of more specific strategies is necessary in order to
use this approach in gene expression control.
libraries have been successfully implemented in studies of the
function of coding (Chen et al., 2015) and non-coding RNAs
(Copeland et al., 2001; Kim and Kim, 2014; Ma et al., 2014).
Targeting of specific loci allows the disruption of genes by
indels (short insertions or deletions) during double-strand break
(DSB) repair, as well as the creation of seamless knock-ins,
point mutations, and more. Nonetheless, gene correction and
knock-ins are still too inefficient for most clinical applications.
A CRISPR Regulator
Nuclease-dead Cas9 (dCas9) is catalytically inactive—due to
two point mutations in its nuclease domains—each cutting
a single DNA strand. Yet, it retains its gRNA binding and
DNA target capabilities. Therefore, it becomes an RNA-guided
DNA-binding protein (Gilbert et al., 2013; Larson et al., 2013).
Similarly to the abovementioned TALEs fused to transcriptional
effectors, dCas9 has been adapted for transcription modulation
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BOX 3 | SITE-SPECIFIC RECOMBINASES (SSRS).
SSRs are sophisticated scientific tools that provide the possibility of precise manipulation of genomic DNA. Best known recombinases are: Vika, VCre, phiC31
integrase, Dre, Nigri/nox, Panto/pox, Flp, Dre and Cre (Sauer and McDermott, 2004; Karimova et al., 2016; Kawano et al., 2016). Once a recombinase recognizes
two specific sites, it recombines them into one, excising the flanked DNA region. An exception of this rule is when the recognition sites are in opposite directions, in
such case the area between them is inverted.
As recombinases require the specific insertion of recognition sites in the genome, and since they have been multiple times reviewed elsewhere, we will just mention
that these methods have also been modified so they can be regulated: (1) by chemicals, examples are the tamoxifen-inducible Cre–ER2 by binding a mutant estrogen
receptor to prompt translocation of Cre into the nucleus, or rapamycin-CID of split Cre (Banaszynski et al., 2005). (2) by optogenetics by use of complementing Cre
fragments fused to either magnets or CRY2-CIB1 (Feil et al., 1997; Jullien, 2003; Kennedy et al., 2010; Duyne, 2014; Gonzalez et al., 2015; Kawano et al., 2016).
of endogenous genes by either turning them OFF (CRISPRi,
CRISPR interference) or ON (CRISPRa, CRISPR activator) and
even fused to Fok1 to generate duoble-dCas9-Fok1 that were
expected to have less off-target effects (Guilinger et al., 2014; Tsai
et al., 2014).
Turning genes off has been achieved solely by targeting
dCas9 to the promoter of a gene, although this often results
in only partial disruption of gene transcription (Mali Prashant,
2014). CRISPRi goes one step further by fusing dCas9 to a
protein known to recruit transcriptional repressors (TRs) such
as chromatin-modifying chromo shadow domain of HP1α, the
Kruppel associated box protein (KRAB), or the WRPW domain
of Hes1, resulting in virtually complete gene repression (Qi
et al., 2013; Keung and Khalil, 2016; Figure 10B). Additionally,
for better results, the scaffold of gRNAs have been modified
by inclusion of RNA stem-loops that are specifically bound by
RNA-loop-binding proteins (see Table 1), such as MS2, fused
with TRs (Zalatan et al., 2015; see Table 1 and Figure 12B).
CRISPRi can silence both coding and noncoding genes, such
as long noncoding RNAs (lncRNAs) and microRNA (miRNA)
(Gilbert et al., 2013, 2014; Larson et al., 2013; Zhao et al., 2014).
Moreover, CRISPRi can be applied to organisms that lack the
RNAi machinery such as Saccharomyces cerevisiae (Drinnenberg
et al., 2011).
At the other end, CRISPRa is used for gene transcription
activation (Gilbert et al., 2014), where dCas9 has been fused to
a TA such as VP64 or VP128 (Larson et al., 2013; Figure 10C).
A potentiated CRISPRa exists, where dCas9 was modified with
a tandem peptide tail that is then recognized by an intracellular
antibody fused with a TA (VP64) (called SunTag) (Farzadfard
et al., 2013; Tanenbaum et al., 2014). The multimerisation of TAs
has also been achieved by use of dRNAs (dead gRNAs). dRNAs
contain 14- to 15-bp target sequences and MS2-binding loops
and can activate gene expression without inducing DSBs even
when using an active Cas9. Originally, it was used for orthogonal
gene knockout and transcriptional activation in human cells
(Dahlman et al., 2015).
Since the CRISPR/Cas9 and dCas9 systems are always active,
modifications to make them inducible are desirable. Once again,
the techniques discussed above came to aid.
The first inducible CRISPR was a split-Cas9 composed by
the C-terminal fragment and N-terminal fragment of Cas9—
Cas9(C) and Cas9(N)—fused to FKBP or FRB, respectively. In
the presence of rapamycin, Cas9(N)-FRB dimerises to Cas9(C)-
FKBP formed a functional Cas9 (Banaszynski et al., 2005;
TABLE 1 | RNA loops and binding proteins.
RNA loop RNA-loop binding
protein
References
MS2-binding site (MBS) MS2 coat protein
(MCP)
Bertrand et al., 1998;
Romaniuk et al., 1987
Lambda boxB RNA
sequence
Phage lambda N
protein (λN22)
Daigle and Ellenberg, 2007
QB Stem-loop QB coating protein Rumnieks and Tars, 2014
PP7 RNA sequence PP7 coating protein Lim et al., 2001; Lim and
Peabody, 2002
Box B nut L/R phage HK022 Nun
protein
Chattopadhyay et al., 1995;
Van Gilst et al., 1997
Amino-terminal
RNA-binding domain of
U1 snRNP A (U1A)
U1A protein Moras and Poterszman,
1995; Oubridge et al., 1994
Nanos Response
Elements (NRE)
NRE-specific protein
e.g., Pumilio
Murata and Wharton, 1995;
Wharton and Struhl, 1991
RNA 3D structure is highly complex, which is associated with a number of its functions.
RNA loops are structures which result from base pairing and can perform multiple
functions such as binding to proteins, RNA or DNA. RNA-loops have been used to tag
mRNA (Figure 12B) as well as to bring transcriptional regulators to the modified gRNA-
loops of CRISPR/Cas9 (see text for more details). Here, we list the stem-loop structures
known to bind to specific proteins.
Zetsche et al., 2015b). Since spatial separation of the fragments
can decrease background activity, caused by spontaneous auto-
assembly of Cas9, Cas9(N)-FRB was directed to the nucleus via
two nuclear localization signals whilst Cas9(C)-FKBP carried a
nuclear export signal.
Using the tet-inducible expression system, named Tet-on/Tet-
off, a doxycycline-inducible Cas9 was generated (González et al.,
2014; Dow et al., 2015). Upon addition of doxycycline, Cas9 was
expressed to introduce monoallelic and biallelic indels, as well as
frame shift mutations, in multiple target loci (Dow et al., 2015).
However, this method is slow as it requires transcription and
translation of Cas9.
As in other chemical-induced methods, the use of
small molecules produces adverse effects such as those of
rapamycin/doxycycline mentioned above. Another disadvantage
arises from slow diffusion, causing difficulties in their rapid
removal (Nihongaki et al., 2015). Finally, in addition to the side
effects, the use of chemicals result in universal targeting and
dose-responses that cannot be properly controlled in vivo.
Since no othermethod outclasses the spatiotemporal precision
of optical stimulation, a photoactivatable Cas9 (paCas9) was
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designed based upon the split design (above) but instead
using the CRY2/CIB1 optogenetic pair. Which was unsuccessful
at first, but the group of investigators lead by Nihongaki
replaced CRY2/CIB1 with other photodimerising proteins called
Magnets (positive—pMag and negative—nMag)—previously
reported by Kawano et al. (2015). Upon light activation, the
split fragments of Cas9, (Cas9N) (residues 2-713) and Cas9C
(residues 714-1,368), were united to form a fully functional Cas9.
Both possible conformations—Cas9N-pMag/Cas9C-nMag and
Cas9N-nMag/Cas9C-pMag showed light-triggered Cas9 activity.
All other features of full-length Cas9 remained unaffected, such
as the PAM specificity and its nuclease activity on genomic DNA.
The paCRISPR was also adapted for transcriptional activation
(paCRISPRa) (Nihongaki et al., 2015; Figure 10D).
Due to the rapid Magnets’ dissociation properties (Nihongaki
et al., 2015), paCRISPR is likely not fully amenable to in vivo
applications, which would require long photostimulation periods
and thereby the immobilization of the organism. In this vein, a
system where light would induce a long-lasting effect would be
far more desirable.
More to CRISPR
The resounding success of CRISPR/Cas9 has triggered a
search for other CRISPR techniques that could work better
or distinctively. This has led to the discovery of a shorter
Cas9 that potentially can fit in viral genomes other than
lentiviruses for gene delivery and therapy (Friedland et al., 2015).
Another discovery was Cpf1 which is a type V CRISPR effector
endonuclease.
The most notable features of CRISPR/Cpf1 are: the absence
of tracrRNA, its crRNA (42–44 nucleotides) shorter than Cas9
gRNA (more than 100 nucleotides), reducing costs (Fagerlund
et al., 2015), and there are significant differences in the
PAM sequences of Cpf1 and Cas9 i.e., 5′-T-rich vs. 3′-G-
rich, respectively. Furthermore, Cpf1 uses an entirely different
mechanism of target recognition, and cleaves producing DNA
over-hangs (Zetsche et al., 2015a; Gao et al., 2016), unlike Cas9
which makes blunt cuts. Thus, Cpf1 has been suggested as an
alternative to the classic CRISPR/Cas9. It is early days and there
still is some controversy on the efficacy of Cpf1, having groups
reporting great effectiveness (Kleinstiver et al., 2016) whereas
others do not (Kim et al., 2016; Tóth et al., 2016). Undoubtedly,
the specificity of Cpf1 is one of its greatest opportunities as an
additional gene editor, in particular for AT-rich regions, as well
as for gene editing of protozoa or organisms that have genomes
with high AT content.
These CRISPR tools may be used in combination e.g., in
studies on gene regulation, when there is need to target different
sequences, which can be achieved using different gRNAs and
crRNAs (Fagerlund et al., 2015).
Editing genes is a sound approach to study their functions, yet
cell control requires that gene expression is modulated, which can
only be accomplished via epigenetic editing.
NATURE OR NURTURE?
Genomic accessibility is controlled by a series of epigenetic
modifications that include DNA methylation, and histone
methylation or acetylation. DNA is methylated by
methyl-transferases (DNMT) and demethylated by TET
hydroxylases, while histones are acetylated by histone acetyl-
transferases (HATs), deacetylated by histone deacetylases
(HDACs), methylated by histone methyl-transferases
(HMTs) and demethylated by histone demethylases (HDMs)
(Arrowsmith et al., 2012; Kooistra and Helin, 2012; Jin et al.,
2015).
DNA methylation of CpG islands is often found in the
promoters of non-expressing genes, and thus hypothesized as a
repressing mark. To determine if this assumption was correct,
two independent research groups used TALEs or dCas9 to
deliver the catalytic domain of Ten 11 Translocation hydroxylase
(TET1) to methylated CpG regions of promoters in mammalian
cells. Demethylation of CpG islands lead to upregulated gene
expression of endogenous genes, proving that DNA methylation
indeed functions, in most cases, as a repression mark (Maeder
et al., 2013; Xu X. et al., 2016; Figure 11A).
Histone-3 lysine 9 (H3K9) di- or tri-methylation has been
correlated to the compaction of chromatin and gene repression.
During cell differentiation, for example during EMT, epithelial
cells gain of mesenchymal cell characteristics by repression of
epithelial-specific genes such as E-cadherin. Repression of this
gene has been attributed to H3K9 di-methylation by Snail1. In
this vein, Cho and collaborators tested the effects of methylation
of histones by using TALE-TSET (a chimera of the E-Box region
of Snail binding site with the SET domain of EHMT – an
HMT). The increase of histone H3K9 di-methylation repressed
the expression of the target gene, E-cadherin, triggering a more
migratory and invasive cell phenotype as expected (Cho et al.,
2015).
Acetylation of histone 3 lysine 27 (H3K27), a mark often
associated with open chromatin, has also been achieved using
a fusion of dCas9 with human acetyltransferase p300 targeting
the promoters of the following genes: MYOD (Myogenic
Differentiation 1), IL1R (Interleukin 1 Receptor Type 1), OCT4
(Octamer-Binding Protein 4), which provoked transcriptional
activation of the downstream genes (Hilton et al., 2015).
Several other epigenetic modifications have also been
rewritten, such as reduced histone acetylation by dCas9-
LSD1—anHDM; histonemethylation (H3K9 tri-methylation) by
dCas9-KRAB (CRISPRi) (Figure 10B); or CpG methylation by
dCas9-DNMT3A—DNA methyltransferase (Kearns et al., 2015;
Thakore et al., 2015; Vojta et al., 2016; Figure 11A). For a recent
review documenting more examples refer to (Laufer et al., 2015).
Since epigenetic marks play an essential role in cell
differentiation, these techniques have enormous potential for in
vivo applications. Modifications such as LITE or paCRISPR will
surely be applied to control specific cells at specific times e.g.,
during embryo development for a more detailed understanding
of epigenetic regulation and function.
We consider RNA as the last frontier when it comes to
manipulation, this is largely due to the plethora and complexity
of RNA types and functions, and the continuously changing
conformation of these molecules. Most research has focused
on degrading mRNA but new and more powerful techniques
are appearing that could also revolutionize how we can
manipulate RNA.
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FIGURE 11 | Epigenetic modulation. (A) CRISPR/TALE-targeted chromatic modification, dCas9 or TALEs as DNA binding domains may deliver several modifiers
(epigenetic editors) which can modify DNA or chromatin structure and thus regulate expression of endogenous genes. Using these methods several epigenetic
modifications have been achieved such as DNA methylation or demethylation, histone acetylation or methylation depending of the epigenetic editor used. (B)
CRISPR-Display (CRISPR-Disp) uses the properties of long non-coding RNA molecules, which can act as scaffold for effectors (see Figure 12A). The functional RNA
domains fused to gRNAs at multiple points, what allowed the display of RNA-protein complexes to genomic loci.
CONTROLLING RNA
Using small oligonucleotides, such as endogenous (miRNA)
(Fabian et al., 2010), synthetic RNA (shRNA, siRNA), or other
nucleic acid analogs (locked nucleic acids LNA, morpholino, 2′-
O-methyl RNA oligo) (Cooper et al., 2009), it is possible to block
gene expression. Despite their popularity in cell biology, they can
hardly be regulated, and their effects often account for partial
mRNA-targeting destruction—something that gene editing tools
can outperform at the genomic level resulting in no gene at all
(Evers et al., 2016). Additionally, new gene editing tools that
target RNAs have been found.
Whilst the most of known prokaryotic adaptive immune
systems target DNA substrates (Brouns et al., 2008; Wright
et al., 2016), type III and VI CRISPR systems, e.g. C2c2, directly
interfere with single-stranded RNA (ssRNA) targets carrying
complementary protospacers (Shmakov et al., 2015; Abudayyeh
et al., 2016). Thus, C2c2 can be programmed to cleave specific
RNAs.
RNA cleavage by C2c2 is mediated by catalytic residues found
in the two conserved HEPN domains (Higher Eukaryotes and
Prokaryotes Nucleotide-binding). Double and quadruple HEPN
mutations (R472A, H477A, R1048A, and H1053A) (dead-C2c2,
dC2c2) did not affect C2c2 pre-crRNA cleaving activity, whilst all
these mutants could still bind to target RNA (Abudayyeh et al.,
2016). The ability of C2c2 to produce its own gRNAs allows co-
expression of C2c2 and multiple-gRNAs from RNA polymerase
II promoters for tissue-specific expression in vivo (East-Seletsky
et al., 2016). Up to now, there is no report to the best our
knowledge of any adaptation of C2c2 to eukaryotic cells.
DECODING THE NON-CODING
Among the non-coding RNAs (ncRNAs), a group that includes
siRNAs, miRNAs, circularRNAs, and piRNAs, there is a
heterogeneous group called long non-coding RNAs (lncRNAs)—
RNA molecules longer than 200 nucleotides that do not code
for proteins. LncRNAs are, in fact, the largest ncRNA transcript
class in mammalian cells, with approximately 10,000 lncRNA
genes so far annotated in humans. LncRNAs are emerging as
crucial regulatory factors in cells, as they interact with DNA,
proteins and other RNAs (Espinosa et al., 2016). Although the
roles of most lncRNAs are far from being elucidated, the number
of described lncRNAs is increasing and many reports suggest
they participate in positively or negatively regulation of gene
expression during development and differentiation as well as
in disease conditions (Kornienko et al., 2013; Zhao and Lin,
2015). Some lncRNAs function as scaffolds that assemble protein
complexes to activate or inactivate certain cellular functions (Lee
et al., 2016; Figure 12A). Others function as guides for protein
complexes to genomic loci, while a few others are known to serve
as decoys that remove proteins from target genes (Yang et al.,
2015). A note to the reader: there are potentially many annotated
lncRNAs that do code for proteins or peptides (Espinosa et al.,
2016; Nelson et al., 2016), although the occurrence and relevance
is currently unknown.
To investigate these capabilities, researchers fused functional
lncRNA domains (up to 4.8 kb) at different positions (5′, middle
or 3′) of gRNAs so they could guide dCas9 to genomic loci
of interest. Testing different architectures of CRISPR/dCas9
complexes to display fragments of lncRNAs (CRISPR-Disp)
such as protein-binding cassettes, aptamers or pools of random
sequences, it was shown that the scaffolding abilities of lncRNAs
could be manipulated and targeted to genomic regions of
interest for the control of e.g., gene expression (Figure 11B).
According to the authors, CRISPR-Disp could be potentially
used to ectopically target functional RNAs and ribonucleoprotein
complexes to genomic loci (Shechner et al., 2015). Currently, little
else has been undertaken to deal with lncRNA to control cellular
phenotypes. However, the combination of lncRNAs to inducible
systems (based on optogenetics or small compounds) would be
required for a better understanding of the roles of lncRNAs in
biology and their further applications. LncRNAs are difficult to
study, due to their multiple domains which are able to bind to
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other RNAs, proteins, DNA and even small compounds, yet for
the very same reason, being able to control them is essential to
further understand cellular functions.
The use of RNAs as scaffolds or guides for proteins
and/or RNAs, would require a more detailed understanding
of the changing structure of RNAs. Yet, examples of RNA
domains that are recognized by proteins are known, such
as the RNA stem-loops (structures occur in single-stranded
RNA molecules resulting from unpaired nucleotides in the
middle of complementary sequences) that are recognized by a
series of proteins (Table 1). These loops/recognizing proteins
have been used to tag RNA for localization and tracking
(Figure 12B), as well as to target mRNA localizations to
specific cell compartments e.g., b-actin mRNA with multiple
MS2 stem–loops in its 3′ UTR was dragged to focal adhesion
sites by a fusion of MCP (MS2 loop binding partner) to the
focal adhesion plaques protein vinculin, resulting in high local
translation of b-actin and larger adhesion plaques (Katz et al.,
2012).
In fact, long synthetic RNA scaffolds have already been used
for the modulation of the metabolism of bacteria. Engineered
RNA blocks which contain the PP7 and MS2 binding domains
(Table 1), were assembled into multidimensional scaffolds
with distinct protein-docking sites. These self-assembling RNA
scaffolds enabled the organization of the oxidoreductive enzymes,
resulting in an increase in hydrogen output in bacteria—mainly
by increase of the rate of electron transfer between enzymes
(Delebecque et al., 2011). A similar strategy was used in E.
coli to increase the metabolic output of pentadecane production
by immobilization of enzymes involved in fatty aldehyde and
succinate production into a synthetic RNA scaffold. The authors
suggested that intra-cellular scaffolding of multi-enzymatic
reactions could enhance the direct passing of intermediary
metabolites from one enzyme to another, to increase the amount
of the final product of the pathway (Sachdeva et al., 2014). To
the best of our knowledge, synthetic RNA scaffolds have not been
shown to function in mammalian cells.
CONCLUDING REMARKS
The discovery of a multitude of different proteins, RNAs, and
systems, from all over the kingdoms of life, have brought a wealth
of new “domains” that can be adapted for the generation of novel
tools in molecular and cell biology.
There is need for improvements in these techniques to the full
implementation in multicellular organisms. Protein dimerization
(CID) and destabilization (DD) have been used to some degree
in animals showing their potential but with many shortcomings
too. Several of CID/DD obstructions have been overcome by
optogenetic systems, some of which, e.g., ChR2/NpHR, have
already been used to control specific behaviors in rodents with
astonishing results (Root et al., 2014). This is due to the very
natural functioning of neurons and the light activating responses
of these receptors. Optogenetics, a field just in its infancy, is
already running wild and making strides in our understanding
of living organisms with an incredible precision. This field will
surely provide many more surprises and beautiful tools to study
living organisms at the molecular level in a detail that has never
been previously achieved. Comprehensive cell control will be
required for tissue and organ bioengineering, as foreseen by the
initial prototypes, such as the photocontrollable ray fish cyborg
(Park et al., 2016).
We expect the discovery or creation - by a collective
effort between in silico modeling, bioinformatics and molecular
biology—of far-red responding proteins, for better penetration
in tissues, proteins which respond to uncommon wavelengths—
plenty of room in the green/yellow and the far-red regions (see
Figure 8), for orthogonal molecular activation in the same cell,
as well as smaller and more dynamic domains which could be
easily delivered via viral particles.
The convergence of several of the above-mentioned
techniques will likely be used to create synthetic circuits
resembling natural networks but externally manipulated with
minimal invasiveness, a field rapidly evolving in prokaryotes,
but yet to make an entrance into eukaryotes. This will require
FIGURE 12 | RNA localization and function. (A) Long non-coding RNAs (lncRNAs) play essential roles on the regulation of chromatin structure. Some lncRNAs may
act as scaffolds for several effector proteins which can modify chromatin organization via recruiting chromatin modifiers; (B) Tagging RNA for tracking and visualization
in living cells is possible by using RNA loops and fusion protein fusion which contain RNA loop-binding proteins fused to fluorescent proteins (FPs) such as GFP.
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modification of endogenous loci, insertion of multiple gene
moieties, tightly regulated promoters, feedback mechanisms,
minimal/no unwanted effects, and lack of leakage under
non-stimulating conditions. Finally, activation should involve
minimal disturbance or stress, with no side effects.
What occurred to us when planning this review was to provide
the reader with a Swissknife of cutting-edge molecular biology
techniques to trigger the readers’ imagination to apply them to
their own research, and, in some cases, to make improvements to
this toolkit.
The aging process seems to be accompanied by progressive
changes in epigenetic information (Pal and Tyler, 2016). Thus,
besides cell differentiation, control over the reversible nature of
epigenetic modifications may well lead to a better understanding
of the molecular mechanisms of aging, and potentially help find
targets for drug development or biomedical interventions.
The control of cellular processes should also be applied
to other organisms, in particular organisms that can create
structures such as diatoms. Controlling diatoms’ frustules shape
could generate biocompatible materials that self-assemble into
macro structures for biomedical or industrial purposes.
The potential therapeutic uses of these techniques, one might
envision gene repair, gene removal e.g., HIV, therapeutic viral
self-deleting genome, genome restructuring or correction of
chromosomal polyploidy. We might go further to suggest that
studies on the origin of life could be supplemented with, literally,
new light, by using some of these novel systems.
All in all, the future of cell control is optogenetically bright;
there are many challenges ahead, mostly in areas such as RNA-
control and the role of epigenetic mechanisms to fine-tune
chromatin structure, and cellular function. Gene repair is still too
inefficient at this point, therefore, modifications to improve the
performance of gene editing tools in accuracy and efficiency are
eagerly awaited, in particular.
The systems described in this review are a good start to
envision the future directions in cell biology and bioengineering.
The final goal is to be able to answer biological questions that have
eluded us for centuries and to ultimately generate controllable
living entities not only for biosafety and biopharmaceuticals but
for biomaterials and tissue engineering.
AUTHOR CONTRIBUTIONS
JC, MKi, JK, MKo, and AR collected the information, organized
the text and wrote the manuscript. JC, MKi, JK, AS, and AR
conceptualized the structure and content of the manuscript. AR
prepared all figures. AS andAR coordinated the work. All authors
read and approved the final manuscript.
ACKNOWLEDGMENTS
We are supported by Grants from (1) Polish National Science
Centre no. 2015/17/B/NZ1/01777 and (2) Medical University of
Lublin for Young Scientist MnMb511.
REFERENCES
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M.,
Cox, D. B. T., et al. (2016). C2c2 is a single-component programmable
RNA-guided RNA-targeting CRISPR effector. Science 353:aaf5573.
doi: 10.1126/science.aaf5573
Ahmad, M., and Cashmore, A. R. (1993). HY4 gene of A. thaliana encodes a
protein with chracterostics of a blue-light photoreceptor. Nature 366, 162–166.
doi: 10.1038/366162a0
Airan, R. D., Thompson, K. R., Fenno, L. E., Bernstein, H., and Deisseroth, K.
(2009). Temporally precise in vivo control of intracellular signalling. Nature
458, 1025–1029. doi: 10.1038/nature07926
An, W., Jackson, R. E., Hunter, P., Gögel, S., Van Diepen, M., Liu, K., et al. (2015).
Engineering FKBP-based destabilizing domains to build sophisticated protein
regulation systems. PLoS ONE 10:145783. doi: 10.1371/journal.pone.0145783
Ando, R., Mizuno, H., and Miyawaki, A. (2004). Regulated fast nucleocytoplasmic
shuttling observed by reversible protein highlighting. Science 306, 1370–1373.
doi: 10.1126/science.1102506
Anthony, K., More, A., and Zhang, X. (2014). Activation of silenced cytokine gene
promoters by the synergistic effect of TBP-TALE and VP64-TALE activators.
PLoS ONE 9:95790. doi: 10.1371/journal.pone.0095790
Aramaki, S., and Hatta, K. (2006). Visualizing neurons one-by-one in vivo: optical
dissection and reconstruction of neural networks with reversible fluorescent
proteins. Dev. Dyn. 235, 2192–2199. doi: 10.1002/dvdy.20826
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., and Schapira, M. (2012).
Epigenetic protein families: a new frontier for drug discovery. Nat. Rev. Drug
Discov. 11, 384–400. doi: 10.1038/nrd3674
Bachand, M., Trent, A. M., Bunker, B. C., and Bachand, G. D. (2005). Physical
factors affecting kinesin-based transport of synthetic nanoparticle cargo. J.
Nanosci. Nanotechnol. 5, 718–722. doi: 10.1166/jnn.2005.112
Ballister, E. R., and Lampson, M. A. (2016). Probing mitosis by
manipulating the interactions of mitotic regulator proteins using
Rapamycin-inducible dimerization. Methods Mol. Biol. 1413, 325–331.
doi: 10.1007/978-1-4939-3542-0_20
Ballister, E. R., Riegman, M., and Lampson, M. A. (2014). Recruitment of Mad1 to
metaphase kinetochores is sufficient to reactivate the mitotic checkpoint. J. Cell
Biol. 204, 901–908. doi: 10.1083/jcb.201311113
Balzani, V. V., Credi, A., Raymo, F. M., and Stoddart, J. F. (2000).
Artificial molecular machines. Angew. Chem. Int. Ed. Engl. 39, 3348–3391.
doi: 10.1002/1521-3773(20001002)39:19<3348::AID-ANIE3348>3.0.CO;2-X
Banaszynski, L. A., Chen, L., Maynard-Smith, L. A., Ooi, A. G. L., and Wandless,
T. J. (2006). A rapid, reversible, and tunable method to regulate protein
function in living cells using synthetic small molecules. Cell 126, 995–1004.
doi: 10.1016/j.cell.2006.07.025
Banaszynski, L. A., Liu, C. W., and Wandless, T. J. (2005). Characterization of
the FKBP-rapamycin-FRB ternary complex. J. Am. Chem. Soc. 127, 4715–4721.
doi: 10.1021/ja043277y
Barakate, A., and Stephens, J. (2016). An overview of CRISPR-Based tools
and their improvements: new opportunities in understanding plant-
pathogen interactions for better crop protection. Front. Plant Sci. 7:765.
doi: 10.3389/fpls.2016.00765
Bear, J. E., Loureiro, J. J., Libova, I., Fässler, R., Wehland, J., and
Gertler, F. B. (2000). Negative regulation of fibroblast motility by
Ena/VASP proteins. Cell 101, 717–728. doi: 10.1016/S0092-8674(00)
80884-3
Bertrand, E., Chartrand, P., Schaefer, M., Shenoy, S. M., Singer, R. H., and Long,
R. M. (1998). Localization of ASH1 mRNA particles in living yeast.Mol. Cell 2,
437–445. doi: 10.1016/S1097-2765(00)80143-4
Bikard, D., andMarraffini, L. A. (2013). Control of gene expression by CRISPR-Cas
systems. F1000Prime Rep. 5:47. doi: 10.12703/P5-47
Blobel, G., and Dobberstein, B. (1975). Transfer of proteins across membranes.
I. Presence of proteolytically processed and unprocessed nascent
immunoglobulin light chains on membrane-bound ribosomes of murine
myeloma. J. Cell Biol. 67, 835–851.
Frontiers in Chemistry | www.frontiersin.org 20 March 2017 | Volume 5 | Article 12
Czapin´ski et al. Controlling Cellular Behavior
Boch, J., Scholze, H., Schornack, S., Landgraf, A., Hahn, S., Kay, S., et al. (2009).
Breaking the code of DNA binding specificity of TAL-type III effectors. Science
326, 1509–1512. doi: 10.1126/science.1178811
Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G., and Deisseroth, K. (2005).
Millisecond-timescale, genetically targeted optical control of neural activity.
Nat. Neurosci. 8, 1263–1268. doi: 10.1038/nn1525
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H.,
Snijders, A. P. L., et al. (2008). Small CRISPR RNAs guide antiviral defense in
Prokaryotes. Science 321, 960–964. doi: 10.1126/science.1159689
Buckley, C. E., Moore, R. E., Reade, A., Goldberg, A. R., Weiner, O. D.,
and Clarke, J. D. W. (2016). Reversible optogenetic control of subcellular
protein localization in a live Vertebrate Embryo. Dev. Cell 36, 117–126.
doi: 10.1016/j.devcel.2015.12.011
Carter, C. W., andWolfenden, R. (2015). tRNA acceptor stem and anticodon bases
form independent codes related to protein folding. Proc. Natl. Acad. Sci. U.S.A.
2015, 201507569. doi: 10.1073/pnas.1507569112
Cermak, T., Doyle, E. L., Christian, M., Wang, L., Zhang, Y., Schmidt, C.,
et al. (2011). Efficient design and assembly of custom TALEN and other TAL
effector-based constructs for DNA targeting. Nucleic Acids Res. 39, e82–e82.
doi: 10.1093/nar/gkr218
Chattopadhyay, S., Hung, S. C., Stuart, A. C., Palmer A. G. III., Garcia-Mena,
J., Das, A., et al. (1995). Interaction between the phage HK022 Nun protein
and the nut RNA of phage l. Proc. Natl. Acad. Sci. U.S.A. 92, 12131–12135.
doi: 10.1073/pnas.92.26.12131
Chen, D., Gibson, E. S., and Kennedy, M. J. (2013). A light-triggered protein
secretion system. J. Cell Biol. 201, 631–640. doi: 10.1083/jcb.201210119
Chen, S., Sanjana, N. E., Zheng, K., Shalem, O., Lee, K., Shi, X., et al. (2015).
Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and
Metastasis. Cell 160, 1246–1260. doi: 10.1016/j.cell.2015.02.038
Chen, X., Wang, X., Du, Z., Ma, Z., and Yang, Y. (2013). “Spatiotemporal control of
gene expression in mammalian cells and in mice using the LightOn system,” in
Current Protocols in Chemical Biology (Hoboken, NJ: John Wiley & Sons, Inc.),
111–129. doi: 10.1002/9780470559277.ch120267
Cheng, C., and Stoddart, J. F. (2016). Wholly synthetic molecular machines.
Chemphyschem 1780–1793. doi: 10.1002/cphc.201501155
Cho, H.-S., Kang, J. G., Lee, J.-H., Lee, J.-J., Jeon, S. K., Ko, J.-H., et al.
(2015). Direct regulation of E-cadherin by targeted histone methylation
of TALE-SET fusion protein in cancer cells. Oncotarget 6, 23837–23844.
doi: 10.18632/oncotarget.4340
Chow, B. Y., Han, X., Dobry, A. S., Qian, X., Chuong, A. S., Li, M., et al.
(2010). High-performance genetically targetable optical neural silencing by
light-driven proton pumps. Nature 463, 98–102. doi: 10.1038/nature08652
Christie, J. M., Arvai, A. S., Baxter, K. J., Heilmann, M., Ashley, J.,
Hara, A. O., et al. (2012). Plant UVR8 photoreceptor senses UV-B by
Tryptophan-mediated disruption of cross-dimer salt Bridges. 335, 1492–1496.
doi: 10.1126/science.1218091.Plant
Christie, J. M., Salomon, M., Nozue, K., Wada, M., and Briggs, W. R. (1999). LOV
(light, oxygen, or voltage) domains of the blue-light photoreceptor phototropin
(nph1): binding sites for the chromophore flavin mononucleotide. Proc. Natl.
Acad. Sci. U.S.A. 96, 8779–8783.
Chung, J., Kuo, C. J., Crabtree, G. R., and Blenis, J. (1992). Rapamycin-FKBP
specifically blocks growth-dependent activation of and signaling by the 70 kd
S6 protein kinases. Cell 69, 1227–1236.
Collin, J. P., Dietrich-Buchecker, C., Gaviña, P., Jimenez-Molero, M. C., and
Sauvage, J. P. (2001). Shuttles and muscles: linear molecular machines
based on transition metals. Acc. Chem. Res. 34, 477–487. doi: 10.1021/ar00
01766
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., et al. (2013).
Multiplex genome engineering using CRISPR/Cas systems. Science 339,
819–823. doi: 10.1126/science.1231143
Cooper, C., Guo, J., Yan, Y., Chooniedass-Kothari, S., Hube, F., Hamedani,
M. K., et al. (2009). Increasing the relative expression of endogenous non-
coding Steroid Receptor RNA Activator (SRA) in human breast cancer
cells using modified oligonucleotides. Nucleic Acids Res. 37, 4518–4531.
doi: 10.1093/nar/gkp441
Copeland, N. G., Jenkins, N. A., and Court, D. L. (2001). Recombineering: a
powerful new tool for mouse functional genomics. Nat. Rev. Genet. 2, 769–779.
doi: 10.1038/35093556
Crefcoeur, R. P., Yin, R., Ulm, R., and Halazonetis, T. D. (2013). Ultraviolet-B-
mediated induction of protein-protein interactions in mammalian cells. Nat.
Commun. 4:1779. doi: 10.1038/ncomms2800
Crosson, S., Rajagopal, S., and Moffat, K. (2003). The LOV domain family:
photoresponsive signaling modules coupled to diverse output domains.
Biochemistry 42, 2–10. doi: 10.1021/bi026978l
Dahlman, J. E., Abudayyeh, O. O., Joung, J., Gootenberg, J. S., Zhang,
F., and Konermann, S. (2015). Orthogonal gene knockout and activation
with a catalytically active Cas9 nuclease. Nat. Biotechnol. 33, 1159–1161.
doi: 10.1038/nbt.3390
Daigle, N., and Ellenberg, J. (2007). LambdaN-GFP: an RNA reporter system for
live-cell imaging. Nat. Methods 4, 633–636. doi: 10.1038/nmeth1065
Delebecque, C. J., Lindner, A. B., Silver, P. A., and Aldaye, F. A. (2011).
Organization of intracellular reactions with rationally designed RNA
assemblies. Science 333, 470–474. doi: 10.1126/science.1206938
DeRose, R., Miyamoto, T., and Inoue, T. (2013). Manipulating signaling at will:
chemically-inducible dimerization (CID) techniques resolve problems in cell
biology. Pflug. Arch. 465, 409–417. doi: 10.1007/s00424-012-1208-6
Di Ventura, B., and Kuhlman, B. (2016). Go in! Go out! Inducible
control of nuclear localization. Curr. Opin. Chem. Biol. 34, 62–71.
doi: 10.1016/j.cbpa.2016.06.009
Dohmen, R. J., Wu, P., and Varshavsky, A. (1994). Heat-inducible degron:
a method for constructing temperature-sensitive mutants. Science 263,
1273–1276.
Dow, L. E., Fisher, J., O’Rourke, K. P., Muley, A., Kastenhuber, E. R., Livshits,
G., et al. (2015). Inducible in vivo genome editing with CRISPR-Cas9. Nat.
Biotechnol. 33, 390–394. doi: 10.1038/nbt.3155
Drinnenberg, I. A., Fink, G. R., and Bartel, D. P. (2011). Compatibility
with killer explains the rise of RNAi-deficient fungi. Science 333:1592.
doi: 10.1126/science.1209575
Duyne, G. D., Van (2014). Cre Recombinase. Microbiol. Spectr. 2, 1–16.
doi: 10.1128/microbiolspec
East-Seletsky, A., O’Connell, M. R., Knight, S. C., Burstein, D., Cate, J. H.
D., Tjian, R., et al. (2016). Two distinct RNase activities of CRISPR-C2c2
enable guide-RNA processing and RNA detection. Nature 538, 270–273.
doi: 10.1038/nature19802
Espinosa, J. M., Cech, T. R., Steitz, J. A., Lai, F., Orom, U. A., Cesaroni, M., et al.
(2016). Revisiting lncRNAs: how do you know yours is not an eRNA?Mol. Cell
62, 1–2. doi: 10.1016/j.molcel.2016.03.022
Etoc, F., Lisse, D., Bellaiche, Y., Piehler, J., Coppey, M., and Dahan, M. (2013).
Subcellular control of Rac-GTPase signalling by magnetogenetic manipulation
inside living cells. Nat. Nanotechnol. 8, 193–198. doi: 10.1038/nnano.
2013.23
Evers, B., Jastrzebski, K., Heijmans, J. P. M., Grernrum, W., Beijersbergen, R.
L., and Bernards, R. (2016). CRISPR knockout screening outperforms shRNA
and CRISPRi in identifying essential genes. Nat. Biotechnol. 34, 631–633.
doi: 10.1038/nbt.3536
Fabian, M. R., Sonenberg, N., and Filipowicz, W. (2010). Regulation of mRNA
translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351–379.
doi: 10.1146/annurev-biochem-060308-103103
Fagerlund, R. D., Staals, R. H. J., Fineran, P. C., Dy, R., Richter, C., Salmond,
G., et al. (2015). The Cpf1 CRISPR-Cas protein expands genome-editing tools.
Genome Biol. 16, 251. doi: 10.1186/s13059-015-0824-9
Fallis, A. (2009). An auxin-based degron system for the rapid
depletion of proteins in nonplant cells. Nat. Methods 53, 1689–1699.
doi: 10.1017/CBO9781107415324.004
Farzadfard, F., Perli, S. D., and Lu, T. K. (2013). Tunable and multifunctional
eukaryotic transcription factors based on CRISPR/Cas. ACS Synth. Biol. 2,
604–613. doi: 10.1021/sb400081r
Feil, R., Wagner, J., Metzger, D., and Chambon, P. (1997). Regulation of
Cre recombinase activity by mutated estrogen receptor ligand-binding
domains. Biochem. Biophys. Res. Commun. 237, 752–757. doi: 10.1006/bbrc.19
97.7124
Feng, S., and Arnold, D. B. (2016). Techniques for studying protein trafficking
and molecular motors in neurons. Cytoskeleton (Hoboken) 73, 508–515.
doi: 10.1002/cm.21274
Feringa, B. L. (2007). The art of building small: from molecular switches to
molecular motors. J. Org. Chem. 72, 6635–6652. doi: 10.1021/jo070394d
Frontiers in Chemistry | www.frontiersin.org 21 March 2017 | Volume 5 | Article 12
Czapin´ski et al. Controlling Cellular Behavior
Fischer, E. S., Park, E., Eck, M. J., and Thomä, N. H. (2016). SPLINTS: Small-
molecule protein ligand interface stabilizers. Curr. Opin. Struct. Biol. 37,
115–122. doi: 10.1016/j.sbi.2016.01.004
Friedland, A. E., Baral, R., Singhal, P., Loveluck, K., Shen, S., Sanchez, M., et al.
(2015). Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-
in-one adeno-associated virus delivery and paired nickase applications.Genome
Biol. 16:257. doi: 10.1186/s13059-015-0817-8
Furuta, A., Amino, M., Yoshio, M., Oiwa, K., Kojima, H., and Furuta, K. (2017).
Creating biomolecular motors based on dynein and actin-binding proteins.
Nat. Nanotechnol. 12, 233–237. doi: 10.1038/nnano.2016.238
Gao, P., Yang, H., Rajashankar, K. R., Huang, Z., and Patel, D. J. (2016).
Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism
for crRNA-mediated target DNA recognition. Cell Res. 26, 901–913.
doi: 10.1038/cr.2016.88
Gasiunas, G., Barrangou, R., Horvath, P., and Siksnys, V. (2012). Cas9-crRNA
ribonucleoprotein complex mediates specific DNA cleavage for adaptive
immunity in bacteria. Proc. Natl. Acad. Sci. U.S.A. 109, E2579–E2586.
doi: 10.1073/pnas.1208507109
Gasser, C., Taiber, S., Yeh, C.-M., Wittig, C. H., Hegemann, P., Ryu, S.,
et al. (2014). Engineering of a red-light-activated human cAMP/cGMP-
specific phosphodiesterase. Proc. Natl. Acad. Sci. U.S.A. 111, 8803–8808.
doi: 10.1073/pnas.1321600111
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead,
E. H., et al. (2014). Genome-scale CRISPR-mediated control of gene repression
and activation. Cell 159, 647–661. doi: 10.1016/j.cell.2014.09.029
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., et al.
(2013). XCRISPR-mediated modular RNA-guided regulation of transcription
in eukaryotes. Cell 154, 442–451. doi: 10.1016/j.cell.2013.06.044
Gonzalez, B., Schwimmer, L. J., Fuller, R. P., Ye, Y., Asawapornmongkol, L.,
and Barbas, C. F. (2010). Modular system for the construction of zinc-finger
libraries and proteins. Nat. Protoc. 5, 791–810. doi: 10.1038/nprot.2010.34
González, F., Zhu, Z., Shi, Z. D., Lelli, K., Verma, N., Li, Q. V., et al.
(2014). An iCRISPR platform for rapid, multiplexable, and inducible genome
editing in human pluripotent stem cells. Cell Stem Cell 15, 215–226.
doi: 10.1016/j.stem.2014.05.018
Gonzalez, I., Munita, R., Agirre, E., Dittmer, T. A., Gysling, K., Misteli, T.,
et al. (2015). A lncRNA regulates alternative splicing via establishment of
a splicing-specific chromatin signature. Nat. Struct. Mol. Biol. 22, 370–376.
doi: 10.1038/nsmb.3005
Grizot, S., Smith, J., Daboussi, F., Prieto, J., Redondo, P., Merino, N., et al. (2009).
Efficient targeting of a SCID gene by an engineered single-chain homing
endonuclease. Nucleic Acids Res. 37, 5405–5419. doi: 10.1093/nar/gkp548
Guilinger, J. P., Thompson, D. B., and Liu, D. R. (2014). Fusion of catalytically
inactive Cas9 to FokI nuclease improves the specificity of genomemodification.
Nat. Biotechnol. 32, 577–582. doi: 10.1038/nbt.2909
Guru, A., Post, R. J., Ho, Y.-Y., and Warden, M. R. (2015). Making
Sense of Optogenetics. Int. J. Neuropsychopharmacol. 18:pyv079.
doi: 10.1093/ijnp/pyv079
Haugwitz, M., Garachtchenko, T., Nourzaie, O., Gandlur, S., and Sagawa, H.
(2008). Rapid, on-demand protein stabilization and destabilization using the
ProteoTunerTM systems. Nat. Methods 5. doi: 10.1038/nmeth.f.223
Haurwitz, R. E., Jinek, M., Wiedenheft, B., Zhou, K., and Doudna, J. A. (2010).
Sequence- and structure-specific RNA processing by a CRISPR endonuclease.
Science 329, 1355–1358. doi: 10.1126/science.1192272
Haurwitz, R. E., Sternberg, S. H., and Doudna, J. A. (2012). Csy4 relies on an
unusual catalytic dyad to position and cleave CRISPR RNA. EMBO J. 31,
2824–2832. doi: 10.1038/emboj.2012.107
Hershko, A., Ciechanover, A., Heller, H., Haas, A. L., and Rose, I. A. (1980).
Proposed role of ATP in protein breakdown: conjugation of protein with
multiple chains of the polypeptide of ATP-dependent proteolysis. Proc. Natl.
Acad. Sci. U.S.A. 77, 1783–1786.
Hilton, I. B., M, D. A., Vockley, C. M., Thakore, P. I., Crawford, G. E., Reddy, T. E.,
et al. (2015). Epigenome editing by a {CRISPR-Cas9-based} acetyltransferase
activates genes from promoters and enhancers. Nat. Biotechnol. 33, 510–517.
doi: 10.1038/nbt.3199
Huala, E., Oeller, P. W., Liscum, E., Han, I. S., Larsen, E., and Briggs, W. R. (1997).
Arabidopsis NPH1: a protein kinase with a putative redox-sensing domain.
Science 278, 2120–2123.
Huang, J., Makabe, K., Biancalana, M., Koide, A., and Koide, S. (2009). Structural
basis for exquisite specificity of affinity clamps, synthetic binding proteins
generated through directed domain-interface evolution. J. Mol. Biol. 392,
1221–1231. doi: 10.1016/j.jmb.2009.07.067
Humphrey, J. D., Dufresne, E. R., and Schwartz, M. A. (2014).
Mechanotransduction and extracellular matrix homeostasis. Nat. Rev.
Mol. Cell Biol. 15, 802–812. doi: 10.1038/nrm3896
Inagaki, H. K., Jung, Y., Hoopfer, E. D., Wong, A. M., Mishra, N., Lin, J.
Y., et al. (2014). Optogenetic control of Drosophila using a red-shifted
channelrhodopsin reveals experience-dependent influences on courtship. Nat.
Methods 11, 325–332. doi: 10.1038/nmeth.2765
Inobe, T., Nozaki, M., and Nukina, N. (2015). Artificial regulation of p53 function
by modulating its assembly. Biochem. Biophys. Res. Commun. 467, 322–327.
doi: 10.1016/j.bbrc.2015.09.162
Iskratsch, T., Wolfenson, H., and Sheetz, M. P. (2014). Appreciating force and
shape — the rise of mechanotransduction in cell biology. Nat. Rev. Mol. Cell
Biol. 15, 825–833. doi: 10.1038/nrm3903
Iwamoto, M., Björklund, T., Lundberg, C., Kirik, D., and Wandless, T. J. (2010). A
general chemical method to regulate protein stability in the mammalian central
nervous system. Chem. Biol. 17, 981–988. doi: 10.1016/j.chembiol.2010.07.009
Jacques, S. L. (2013). Corrigendum: optical properties of biological tissues: a
review. Phys. Med. Biol. 58, 5007–5008. doi: 10.1088/0031-9155/58/14/5007
Jansen, V., Alvarez, L., Balbach, M., Strünker, T., Hegemann, P., Kaupp, U. B., et al.
(2015). Controlling fertilization and cAMP signaling in sperm by optogenetics.
Elife 4:e05161. doi: 10.7554/eLife.05161
Jentzsch, K., Wirtz, A., Circolone, F., Drepper, T., Losi, A., Gärtner, W., et al.
(2009). Mutual exchange of kinetic properties by extended mutagenesis in
two short LOV domain proteins from Pseudomonas putida. Biochemistry 48,
10321–10333. doi: 10.1021/bi901115z
Jin, C., Qin, T., Barton, M. C., Jelinek, J., and Issa, J. P. J. (2015). Minimal role of
base excision repair in TET-induced global DNA demethylation in HEK293T
cells. Epigenetics 10, 1006–1013. doi: 10.1080/15592294.2015.1091145
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., and Charpentier,
E. (2012). A programmable dual-RNA-guided DNA endonuclease in adaptive
bacterial immunity. Science 337, 816–821. doi: 10.1126/science.1225829
Jullien, N. (2003). Regulation of Cre recombinase by ligand-induced
complementation of inactive fragments. Nucleic Acids Res. 31, 131e–131.
doi: 10.1093/nar/gng131
Karimova, M., Splith, V., Karpinski, J., Pisabarro, M. T., and Buchholz, F.
(2016). Discovery of Nigri/nox and Panto/pox site-specific recombinase
systems facilitates advanced genome engineering. Sci. Rep. 6:30130.
doi: 10.1038/srep30130
Katz, Z. B., Wells, A. L., Park, H. Y., Wu, B., Shenoy, S. M., and Singer, R. H. (2012).
-Actin mRNA compartmentalization enhances focal adhesion stability and
directs cell migration. Genes Dev. 26, 1885–1890. doi: 10.1101/gad.190413.112
Kawano, F., Okazaki, R., Yazawa, M., and Sato, M. (2016). A photoactivatable Cre-
loxP recombination system for optogenetic genome engineering. Nat. Chem.
Biol. 12, 1059–1064. doi: 10.1038/nchembio.2205
Kawano, F., Suzuki, H., Furuya, A., and Sato, M. (2015). Engineered pairs
of distinct photoswitches for optogenetic control of cellular proteins. Nat.
Commun. 6:6256. doi: 10.1038/ncomms7256
Kearns, N., a, Pham, H., Tabak, B., Genga, R. M., Silverstein, N. J., Garber, M.,
et al. (2015). Functional annotation of native enhancers with a Cas9-histone
demethylase fusion. Nat. Methods 12, 401–403. doi: 10.1038/nmeth.3325
Kelwick, R., MacDonald, J. T., Webb, A. J., and Freemont, P. (2014). Developments
in the tools and methodologies of synthetic biology. Front. Bioeng. Biotechnol.
2:60. doi: 10.3389/fbioe.2014.00060
Kennedy, M. B. (1995). Origin of PDZ (DHR, GLGF) domains. Trends Biochem.
Sci. 20:350. doi: 10.1016/S0968-0004(00)89074-X
Kennedy, M. J., Hughes, R. M., Peteya, L. A., Schwartz, J. W., Ehlers,
M. D., and Tucker, C. L. (2010). Rapid blue-light-mediated induction of
protein interactions in living cells. Nat. Methods 7, 973–975. doi: 10.1038/
nmeth.1524
Keung, A. J., and Khalil, A. S. (2016). A unifying model of epigenetic regulation.
Science 351, 661–662. doi: 10.1126/science.aaf1647
Kim, B., and Lin, M. Z. (2013). Optobiology: optical control of biological
processes via protein engineering. Biochem. Soc. Trans. 41, 1183–1188.
doi: 10.1042/BST20130150
Frontiers in Chemistry | www.frontiersin.org 22 March 2017 | Volume 5 | Article 12
Czapin´ski et al. Controlling Cellular Behavior
Kim, D., Kim, J., Hur, J. K., Been, K. W., Yoon, S., and Kim, J.-S. (2016). Genome-
wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat.
Biotechnol. 34, 863–868. doi: 10.1038/nbt.3609
Kim, D.-S., Gusti, V., Pillai, S. G., andGaur, R. K. (2005). An artificial riboswitch for
controlling pre-mRNA splicing. RNA 11, 1667–1677. doi: 10.1261/rna.2162205
Kim, H., and Kim, J. S. (2014). A guide to genome engineering with programmable
nucleases. Nat. Rev. Genet. 15, 321–334. doi: 10.1038/nrg3686
Kim, Y. G., Cha, J., and Chandrasegaran, S. (1996). Hybrid restriction enzymes:
zinc finger fusions to Fok I cleavage domain. Proc. Natl. Acad. Sci. U.S.A. 93,
1156–1160. doi: 10.1073/pnas.93.3.1156
Kleinstiver, B. P., Tsai, S. Q., Prew, M. S., Nguyen, N. T., Welch, M. M., Lopez, J.
M., et al. (2016). Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in
human cells. Nat. Biotechnol. 34, 869–874. doi: 10.1038/nbt.3620
Konermann, S., Brigham,M. D., Trevino, A. E., Hsu, P. D., Heidenreich, M., Cong,
L., et al. (2013). Optical control of mammalian endogenous transcription and
epigenetic states. Nature 500, 472–476. doi: 10.1038/nature12466
Kooistra, S. M., and Helin, K. (2012). Molecular mechanisms and potential
functions of histone demethylases. Nat. Rev. Mol. Cell Biol. 13, 297–311.
doi: 10.1038/nrm3327
Kopan, R. (2002). Notch: a membrane-bound transcription factor. J. Cell Sci. 115,
1095–1097. Available online at: http://jcs.biologists.org/content/115/6/1095.
long
Kornienko, A. E., Guenzl, P. M., Barlow, D. P., and Pauler, F. M. (2013). Gene
regulation by the act of long non-coding RNA transcription. BMC Biol. 11:59.
doi: 10.1186/1741-7007-11-59
Larson, M. H., Gilbert, L. A., Wang, X., Lim, W. A., Weissman, J. S., and Qi, L. S.
(2013). CRISPR interference (CRISPRi) for sequence-specific control of gene
expression. Nat. Protoc. 8, 2180–2196. doi: 10.1038/nprot.2013.132
Laufer, B. I., Singh, S. M., Groote, M., Verschure, P., Rots, M., Jurkowski,
T., et al. (2015). Strategies for precision modulation of gene expression
by epigenome editing: an overview. Epigenet. Chromatin 8:34.
doi: 10.1186/s13072-015-0023-7
Lee, S., Kopp, F., Chang, T.-C., Sataluri, A., Chen, B., Sivakumar, S., et al.
(2016). Noncoding RNA NORAD regulates genomic stability by sequestering
PUMILIO proteins. Cell 164, 69–80. doi: 10.1016/j.cell.2015.12.017
Levskaya, A., Weiner, O. D., Lim, W. A., and Voigt, C. A. (2009). Spatiotemporal
control of cell signalling using a light- switchable protein interaction. Nature
461, 997–1001. doi: 10.1038/nature08446
Lévy, F., Johnston, J. A., and Varshavsky, A. (1999). Analysis of a conditional
degradation signal in yeast andmammalian cells. Eur. J. Biochem. 259, 244–252.
Li, J., Kim, S. G., and Blenis, J. (2014). Rapamycin: one drug, many effects. Cell
Metab. 19, 373–379. doi: 10.1016/j.cmet.2014.01.001
Li,W., Teng, F., Li, T., and Zhou, Q. (2013). Simultaneous generation and germline
transmission of multiple gene mutations in rat using CRISPR-Cas systems.Nat.
Biotechnol. 31, 684–686. doi: 10.1038/nbt.2652
Lim, F., Downey, T. P., and Peabody, D. S. (2001). Translational repression and
specific RNA Binding by the Coat Protein of the Pseudomonas Phage PP7. J.
Biol. Chem. 276, 22507–22513. doi: 10.1074/jbc.M102411200
Lim, F., and Peabody, D. S. (2002). RNA recognition site of PP7 coat protein.
Nucleic Acids Res. 30, 4138–4144. doi: 10.1093/nar/gkf552
Lin, J. Y., Knutsen, P. M., Muller, A., Kleinfeld, D., and Tsien, R. Y. (2013).
ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial
optogenetic excitation. Nat. Neurosci. 16, 1499–1508. doi: 10.1038/nn.3502
Liu, H., Liu, B., Zhao, C., Pepper, M., and Lin, C. (2011). The action
mechanisms of plant cryptochromes. Trends Plant Sci. 16, 684–691.
doi: 10.1016/j.tplants.2011.09.002
Liu, H., Wang, Q., Liu, Y., Zhao, X., Imaizumi, T., Somers, D. E., et al.
(2013). Arabidopsis CRY2 and ZTL mediate blue-light regulation of the
transcription factor CIB1 by distinct mechanisms. Proc. Natl. Acad. Sci. U.S.A.
110, 17582–17587. doi: 10.1073/pnas.1308987110
Liu, H., Yu, X., Li, K., Klejnot, J., Yang, H., Lisiero, D., et al. (2008). Photoexcited
CRY2 interacts with CIB1 to regulate transcription and floral initiation in
Arabidopsis. Science 322, 1535–1539. doi: 10.1126/science.1163927
Liu, Z., Liu, Y., Chang, Y., Seyf, H. R., Henry, A., Mattheyses, A. L., et al. (2016).
Nanoscale optomechanical actuators for controlling mechanotransduction in
living cells. Nat. Methods 13, 143–146. doi: 10.1038/nmeth.3689
Lokhandwala, J., Silverman, Y., De La Vega, R. I., Hopkins, H. C., Britton, C. W.,
Rodriguez-Iglesias, A., et al. (2016). A native threonine coordinates ordered
water to tune light-oxygen-voltage (LOV) domain photocycle kinetics and
osmotic stress signaling in trichoderma reesei ENVOY. J. Biol. Chem. 291,
14839–14850. doi: 10.1074/jbc.M116.731448
Losi, A., Polverini, E., Quest, B., and Gärtner, W. (2002). First evidence
for phototropin-related blue-light receptors in prokaryotes. Biophys. J. 82,
2627–2634. doi: 10.1016/S0006-3495(02)75604-X
Ma, Y., Zhang, L., and Huang, X. (2014). Genome modification by CRISPR/Cas9.
FEBS J. 281, 5186–5193. doi: 10.1111/febs.13110
Maeder, M. L., Angstman, J. F., Richardson, M. E., Linder, S. J., Cascio, V. M., Tsai,
S. Q., et al. (2013). Targeted DNA demethylation and activation of endogenous
genes using programmable TALE-TET1 fusion proteins. Nat. Biotechnol. 31,
1137–1142. doi: 10.1038/nbt.2726
Maeder, M. L., Thibodeau-Beganny, S., Sander, J. D., Voytas, D. F., and Joung,
J. K. (2009). Oligomerized pool engineering (OPEN): an “open-source”
protocol for making customized zinc-finger arrays. Nat. Protoc. 4, 1471–1501.
doi: 10.1038/nprot.2009.98
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., et al. (2013).
RNA-guided human genome engineering via Cas9. Science 339, 823–826.
doi: 10.1126/science.1232033
Mali Prashant, E. K., and C. G. (2014). Cas9 as a versatile tool for engeneering
biology. NIH Public Access 10, 957–963. doi: 10.1038/nmeth.2649.Cas9
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., et al. (2011). A
TALE nuclease architecture for efficient genome editing. Nat. Biotechnol. 29,
143–148. doi: 10.1038/nbt.1755
Mojica, F. J.M., Díez-Villaseñor, C., García-Martínez, J., andAlmendros, C. (2009).
Short motif sequences determine the targets of the prokaryotic CRISPR defence
system.Microbiology 155, 733–740. doi: 10.1099/mic.0.023960-0
Moras, D., and Poterszman, A. (1995). RNA-Protein Interactions: diverse modes
of recognition. Curr. Biol. 5, 249–251. doi: 10.1016/S0960-9822(95)00051-0
Morawska, M., and Ulrich, H. D. (2013). An expanded tool kit for the
auxin-inducible degron system in budding yeast. Yeast 30, 341–351.
doi: 10.1002/yea.2967
Morsut, L., Roybal, K. T., Xiong, X., Gordley, R. M., Coyle, S. M., Thomson, M.,
et al. (2016). Engineering customized cell sensing and response behaviors using
synthetic notch receptors. Cell 164, 780–791. doi: 10.1016/j.cell.2016.01.012
Moscou, M. J., and Bogdanove, A. J. (2009). A simple cipher governs DNA
recognition by TAL effectors. Science 326, 1501. doi: 10.1126/science.1178817
Müller, K., Engesser, R., Schulz, S., Steinberg, T., Tomakidi, P., Weber,
C. C., et al. (2013). Multi-chromatic control of mammalian gene
expression and signaling. Nucleic Acids Res. 41:e124. doi: 10.1093/nar/
gkt340
Murata, Y., andWharton, R. P. (1995). Binding of pumilio to maternal hunchback
mRNA is required for posterior patterning in drosophila embryos. Cell 80,
747–756. doi: 10.1016/0092-8674(95)90353-4
Mussolino, C., and Cathomen, T. (2012). TALE nucleases: tailored
genome engineering made easy. Curr. Opin. Biotechnol. 23, 644–650.
doi: 10.1016/j.copbio.2012.01.013
Mussolino, C., Morbitzer, R., Lütge, F., Dannemann, N., Lahaye, T., and
Cathomen, T. (2011). A novel TALE nuclease scaffold enables high genome
editing activity in combination with low toxicity. Nucleic Acids Res. 39,
9283–9293. doi: 10.1093/nar/gkr597
Nagel, G., Szellas, T., Huhn, W., Kateriya, S., Adeishvili, N., Berthold, P.,
et al. (2003). Channelrhodopsin-2, a directly light-gated cation-selective
membrane channel. Proc. Natl. Acad. Sci. U.S.A. 100, 13940–13945.
doi: 10.1073/pnas.1936192100
Nelson, B. R., Makarewich, C. A., Anderson, D. M., Winders, B. R., Troupes, C.
D., Wu, F., et al. (2016). A peptide encoded by a transcript annotated as long
noncoding RNA enhances SERCA activity in muscle. Science 351, 271–275.
doi: 10.1126/science.aad4076
Nguyen, M. K., Kim, C. Y., Kim, J. M., Park, B. O., Lee, S., Park, H., et al. (2016).
Optogenetic oligomerization of Rab GTPases regulates intracellular membrane
trafficking. Nat. Chem. Biol. 12, 431–436. doi: 10.1038/nchembio.2064
Ni, M., Tepperman, J. M., and Quail, P. H. (1999). Binding of phytochrome B to
its nuclear signalling partner PIF3 is reversibly induced by light. Nature 400,
781–784. doi: 10.1038/23500
Nihongaki, Y., Kawano, F., Nakajima, T., and Sato, M. (2015). Photoactivatable
CRISPR-Cas9 for optogenetic genome editing. Nat. Biotechnol. 33, 755–760.
doi: 10.1038/nbt.3245
Frontiers in Chemistry | www.frontiersin.org 23 March 2017 | Volume 5 | Article 12
Czapin´ski et al. Controlling Cellular Behavior
Niopek, D., Benzinger, D., Roensch, J., Draebing, T., Wehler, P., Eils, R., et al.
(2014). Engineering light-inducible nuclear localization signals for precise
spatiotemporal control of protein dynamics in living cells. Nat. Commun. 5,
4404. doi: 10.1038/ncomms5404
Niopek, D., Wehler, P., Roensch, J., Eils, R., and Di Ventura, B. (2016).
Optogenetic control of nuclear protein export. Nat. Commun. 7:10624.
doi: 10.1038/ncomms10624
Nishimura, K., Fukagawa, T., Takisawa, H., Kakimoto, T., and Kanemaki, M.
(2009). An auxin-based degron system for the rapid depletion of proteins in
nonplant cells. Nat. Methods 6, 917–922. doi: 10.1038/nmeth.1401
Nissim, L., Perli, S. D., Fridkin, A., Perez-Pinera, P., and Lu, T. K. (2014).
Multiplexed and programmable regulation of gene networks with an integrated
RNA and CRISPR/Cas toolkit in human cells. Mol. Cell 54, 698–710.
doi: 10.1016/j.molcel.2014.04.022
Niu, Y., Shen, B., Cui, Y., Chen, Y., Wang, J., Wang, L., et al. (2014). Generation of
gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in
one-cell embryos. Cell 156, 836–843. doi: 10.1016/j.cell.2014.01.027
Oubridge, C., Ito, N., Evans, P. R., Teo, C. H., and Nagai, K. (1994). Crystal
structure at 1.92A resolution of the RNA-binding domain of the U1A
spliceosomal protein complexed with an RNA hairpin. Nature 372, 432–438.
doi: 10.1038/372432a0
Pal, S., and Tyler, J. K. (2016). Epigenetics and aging. Sci. Adv. 2:e1600584.
doi: 10.1126/sciadv.1600584
Park, S.-J., Gazzola, M., Park, K. S., Park, S., Di Santo, V., Blevins, E. L., et al.
(2016). Phototactic guidance of a tissue-engineered soft-robotic ray. Science
353, 158–162. doi: 10.1126/science.aaf4292
Potorac, I., Rivero-Müller, A., Trehan, A., Kiełbus, M., Jozwiak, K., Pralong,
F., et al. (2016). A vital region for human glycoprotein hormone
trafficking revealed by an LHB mutation. J. Endocrinol. 231, 197–207.
doi: 10.1530/JOE-16-0384
Przybilski, R., Richter, C., Gristwood, T., Clulow, J. S., Vercoe, R. B., and Fineran,
P. C. (2011). Csy4 is responsible for CRISPR RNA processing in Pectobacterium
atrosepticum. RNA Biol. 8, 517–528. doi: 10.4161/rna.8.3.15190
Putyrski, M., and Schultz, C. (2012). Protein translocation as a tool: the current
rapamycin story. FEBS Lett. 586, 2097–2105. doi: 10.1016/j.febslet.2012.04.061
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin,
A. P., et al. (2013). Repurposing CRISPR as an RNA-Guided platform
for sequence- specific control of gene expression. Cell 152, 1173–1183.
doi: 10.1016/j.cell.2013.02.022.Repurposing
Qi, W., Zhu, T., Tian, Z., Li, C., Zhang, W., and Song, R. (2016).
High-efficiency {CRISPR/Cas9} multiplex gene editing using the glycine
{tRNA-processing} system-based strategy in maize. BMC Biotechnol. 16:58.
doi: 10.1186/s12896-016-0289-2
Qin, W., Liang, F., Feng, Y., Bai, H., Yan, R., Li, S., et al. (2015). Expansion
of CRISPR/Cas9 genome targeting sites in zebrafish by Csy4-based RNA
processing. Cell Res. 25, 1074–1077. doi: 10.1038/cr.2015.95
Quintino, L., Manfré, G., Wettergren, E. E., Namislo, A., Isaksson, C., and
Lundberg, C. (2013). Functional neuroprotection and efficient regulation of
GDNF using destabilizing domains in a rodent model of Parkinson’s disease.
Mol. Ther. 21, 2169–2180. doi: 10.1038/mt.2013.169
Rein, M. L., and Deussing, J. M. (2012). The optogenetic (r)evolution.Mol. Genet.
Genomics 287, 95–109. doi: 10.1007/s00438-011-0663-7
Robinson, M. S., Sahlender, D. A., and Foster, S. D. (2010). Rapid inactivation
of proteins by rapamycin-induced rerouting to mitochondria. Dev. Cell 18,
324–331. doi: 10.1016/j.devcel.2009.12.015
Rodriguez-Fraticelli, A. E., Vergarajauregui, S., Eastburn, D. J., Datta, A., Alonso,
M. A., Mostov, K., et al. (2010). The Cdc42 GEF Intersectin 2 controls mitotic
spindle orientation to form the lumen during epithelial morphogenesis. J. Cell
Biol. 189, 725–738. doi: 10.1083/jcb.201002047
Romaniuk, P. J., Lowary, P., Wu, H. N., Stormo, G., and Uhlenbeck, O. C.
(1987). RNA binding site of R17 coat protein. Biochemistry 26, 1563–1568.
doi: 10.1021/bi00380a011
Root, C. M., Denny, C. A., Hen, R., and Axel, R. (2014). The participation of
cortical amygdala in innate, odour-driven behaviour. Nature 515, 269–273.
doi: 10.1038/nature13897
Rumnieks, J., and Tars, K. (2014). Crystal structure of the bacteriophage q?? coat
protein in complex with the rna operator of the replicase gene. J. Mol. Biol. 426,
1039–1049. doi: 10.1016/j.jmb.2013.08.025
Sachdeva, G., Garg, A., Godding, D., Way, J. C., and Silver, P. A. (2014). In vivo
co-localization of enzymes on RNA scaffolds increases metabolic production
in a geometrically dependent manner. Nucleic Acids Res. 42, 9493–9503.
doi: 10.1093/nar/gku617
Sander, J. D., and Joung, J. K. (2014). CRISPR-Cas systems for genome
editing, regulation and targeting. Nat. Biotechnol. 32, 347–355.
doi: 10.1038/nbt.2842.CRISPR-Cas
Sauer, B., and McDermott, J. (2004). DNA recombination with a heterospecific
Cre homolog identified from comparison of the pac-c1 regions of P1-related
phages. Nucleic Acids Res. 32, 6086–6095. doi: 10.1093/nar/gkh941
Schmid-Burgk, J. L., Schmidt, T., Kaiser, V., Höning, K., and Hornung, V. (2013).
A ligation-independent cloning technique for high-throughput assembly
of transcription activator–like effector genes. Nat. Biotechnol. 31, 76–81.
doi: 10.1038/nbt.2460
Shechner, D. M., Hacisuleyman, E., Younger, S. T., and Rinn, J. L. (2015).
Multiplexable, locus-specific targeting of long RNAswith CRISPR-Display.Nat.
Methods 12, 664–670. doi: 10.1038/nmeth.3433
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S.,
Semenova, E., et al. (2015). Discovery and Functional Characterization
of Diverse Class 2 CRISPR-Cas Systems. Mol. Cell 60, 385–397.
doi: 10.1016/j.molcel.2015.10.008
Sigal, N. H., and Dumont, F. J. (1992). Cyclosporin A, FK-506, and Rapamycin:
pharmacologic probes of lymphocyte signal transduction.Annu. Rev. Immunol.
10, 519–560. doi: 10.1146/annurev.iy.10.040192.002511
Skelton, N. J., Koehler, M. F. T., Zobel, K., Wong, W. L., Yeh, S., Pisabarro, M. T.,
et al. (2003). Origins of PDZ domain ligand specificity. Structure determination
and mutagenesis of the erbin PDZ domain. J. Biol. Chem. 278, 7645–7654.
doi: 10.1074/jbc.M209751200
Sternberg, S. H., Haurwitz, R. E., and Doudna, J. A. (2012). Mechanism of substrate
selection by a highly specific CRISPR endoribonuclease. RNA 18, 661–672.
doi: 10.1261/rna.030882.111
Stierl, M., Stumpf, P., Udwari, D., Gueta, R., Hagedorn, R., Losi, A., et al. (2011).
Lightmodulation of cellular cAMP by a small bacterial photoactivated Adenylyl
Cyclase, bPAC, of the Soil Bacterium Beggiatoa. J. Biol. Chem. 286, 1181–1188.
doi: 10.1074/jbc.M110.185496
Strickland, D., Lin, Y., Wagner, E., Hope, C. M., Zayner, J., Antoniou, C.,
et al. (2012). TULIPs: tunable, light-controlled interacting protein tags for cell
biology. Nat. Methods 9, 379–384. doi: 10.1038/nmeth.1904
Tai, K., Quintino, L., Isaksson, C., Gussing, F., and Lundberg, C. (2012).
Destabilizing domains mediate reversible transgene expression in the brain.
PLoS ONE 7:e46269. doi: 10.1371/journal.pone.0046269
Tanenbaum, M. E., Gilbert, L. A., Qi, L. S., Weissman, J. S., and Vale, R. D.
(2014). A protein-tagging system for signal amplification in gene expression
and fluorescence imaging. Cell 159, 635–646. doi: 10.1016/j.cell.2014.09.039
Taslimi, A., Zoltowski, B., Miranda, J. G., Pathak, G. P., Hughes, R.
M., and Tucker, C. L. (2016). Optimized second-generation CRY2–CIB
dimerizers and photoactivatable Cre recombinase. Nat. Chem. Biol. 12, 1–8.
doi: 10.1038/nchembio.2063
Thakore, P. I., MD’lppolito, A., Song, L., Safi, A., Shivakumar, N. K., Kabadi, A. M.,
et al. (2015). Highly specific epigenome editing by {CRISPR-Cas9} repressors
for silencing of distal regulatory elements. Nat. Methods 12, 1143–1149.
doi: 10.1038/nmeth.3630
Thompson, K. M., Syrett, H. A., Knudsen, S. M., and Ellington, A. D. (2002).
Group I aptazymes as genetic regulatory switches. BMC Biotechnol. 2:21.
doi: 10.1186/1472-6750-2-21
Tischer, D., andWeiner, O. D. (2014). Illuminating cell signalling with optogenetic
tools. Nat. Rev. Mol. Cell Biol. 15, 551–558. doi: 10.1038/nrm3837
Tóth, E., Weinhardt, N., Bencsura, P., Huszár, K., Kulcsár, P. I., Tálas, A.,
et al. (2016). Cpf1 nucleases demonstrate robust activity to induce DNA
modification by exploiting homology directed repair pathways in mammalian
cells. Biol. Direct 11:46. doi: 10.1186/s13062-016-0147-0
Tsai, S. Q., Wyvekens, N., Khayter, C., Foden, J. A., Thapar, V., Reyon,
D., et al. (2014). Dimeric CRISPR RNA-guided FokI nucleases for highly
specific genome editing. Nat. Biotechnol. 32, 569–576. doi: 10.1038/
nbt.2908
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., and Gregory, P. D. (2010).
Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11,
636–646. doi: 10.1038/nrg2842
Frontiers in Chemistry | www.frontiersin.org 24 March 2017 | Volume 5 | Article 12
Czapin´ski et al. Controlling Cellular Behavior
van Bergeijk, P., Adrian, M., Hoogenraad, C. C., and Kapitein, L. C. (2015).
Optogenetic control of organelle transport and positioning. Nature 518,
111–114. doi: 10.1038/nature14128
Van Gilst, M. R., Rees, W. A., Das, A., and Von Hippel, P. H. (1997). Complexes
of N antitermination protein of phage lambda with specific and nonspecific
RNA target sites on the nascent transcript. Biochemistry 36, 1514–1524.
doi: 10.1021/bi961920q
Vojta, A., Dobrinic, P., Tadic, V., Bockor, L., Korac, P., Julg, B., et al. (2016).
Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic
Acids Res. 44, 5615–5628. doi: 10.1093/nar/gkw159
Wang, F., and Qi, L. S. (2016). Applications of CRISPR genome engineering in cell
biology. Trends Cell Biol. 26, 875–888. doi: 10.1016/j.tcb.2016.08.004
Wang, H., Vilela, M., Winkler, A., Tarnawski, M., Schlichting, I., Yumerefendi,
H., et al. (2016). LOVTRAP: an optogenetic system for photoinduced protein
dissociation. Nat. Methods 13, 755–758. doi: 10.1038/nmeth.3926
Wang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F.,
et al. (2013). One-step generation of mice carrying mutations in multiple
genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910–918.
doi: 10.1016/j.cell.2013.04.025
Wang, X., Chen, X., and Yang, Y. (2012). Spatiotemporal control of gene
expression by a light-switchable transgene system. Nat. Methods 9, 266–269.
doi: 10.1038/nmeth.1892
Wehler, P., Niopek, D., Eils, R., and Di Ventura, B. (2016). Optogenetic
control of nuclear protein import in living cells using Light-Inducible
Nuclear Localization Signals (LINuS). Curr. Protoc. Chem. Biol. 8, 131–145.
doi: 10.1002/cpch.4
Wesley, R., and Browne, B. L. F. (2006). Making molecular machines work. Nat.
Nanotechnol. 25–35. doi: 10.1038/nnano.2006.45
Wharton, R. P., and Struhl, G. (1991). RNA regulatory elements mediate control of
Drosophila body pattern by the posterior morphogen nanos. Cell 67, 955–967.
doi: 10.1016/0092-8674(91)90368-9
Winters, M. J., Lamson, R. E., Nakanishi, H., Neiman, A. M., and Pryciak, P. M.
(2005). AMembrane Binding Domain in the Ste5 Scaffold Synergizes with Gβγ
Binding to Control Localization and Signaling in Pheromone Response. Mol.
Cell 20, 21–32. doi: 10.1016/j.molcel.2005.08.020
Wolff, S. B. E., Gründemann, J., Tovote, P., Krabbe, S., Jacobson, G. A.,
Müller, C., et al. (2014). Amygdala interneuron subtypes control fear
learning through disinhibition. Nature 509, 453–458. doi: 10.1038/nature
13258
Wood, L., Booth, D. G., Vargiu, G., Ohta, S., deLima Alves, F., Samejima, K., et al.
(2016). Auxin/AID versus conventional knockouts: distinguishing the roles of
CENP-T/W in mitotic kinetochore assembly and stability. Open Biol. 6:150230.
doi: 10.1098/rsob.150230
Wright, A. V., Nuñez, J. K., and Doudna, J. A. (2016). Biology and applications of
CRISPR systems: harnessing nature’s toolbox for genome engineering. Cell 164,
29–44. doi: 10.1016/j.cell.2015.12.035
Wu, D., Hu, Q., Yan, Z., Chen, W., Yan, C., Huang, X., et al. (2012).
Structural basis of ultraviolet-B perception by UVR8. Nature 484, 214–219.
doi: 10.1038/nature10931
Wu, Y. I., Frey, D., Lungu, O. I., Jaehrig, A., Schlichting, I., Kuhlman, B., et al.
(2009). A genetically encoded photoactivatable Rac controls the motility of
living cells. Nature 461, 104–108. doi: 10.1038/nature08241
Xie, K., Minkenberg, B., and Yang, Y. (2015). Boosting CRISPR/Cas9 multiplex
editing capability with the endogenous tRNA-processing system. Proc. Natl.
Acad. Sci. U.S.A. 112, 3570–3575. doi: 10.1073/pnas.1420294112
Xu, L., Zhao, L., Gao, Y., Xu, J., and Han, R. (2016). Empower multiplex cell
and tissue-specific CRISPR-mediated gene manipulation with self-cleaving
ribozymes and tRNA. Nucleic Acids Res. doi: 10.1093/nar/gkw1048. [Epub
ahead of print].
Xu, X., Tao, Y., Gao, X., Zhang, L., Li, X., Zou, W., et al. (2016). A CRISPR-
based approach for targeted DNA demethylation. Cell Discov. 2, 16009.
doi: 10.1038/celldisc.2016.9
Yang, Y., Wen, L., and Zhu, H. (2015). Unveiling the hidden function of long
non-coding RNA by identifying its major partner-protein. Cell Biosci. 5:59.
doi: 10.1186/s13578-015-0050-x
Yeh, B. J., Rutigliano, R. J., Deb, A., Bar-Sagi, D., and Lim, W., a (2007). Rewiring
cellular morphology pathways with synthetic guanine nucleotide exchange
factors. Nature 447, 596–600. doi: 10.1038/nature05851
Yen, L., Svendsen, J., Lee, J.-S., Gray, J. T., Magnier, M., Baba, T., et al. (2004).
Exogenous control of mammalian gene expression throughmodulation of RNA
self-cleavage. Nature 431, 471–476. doi: 10.1038/nature02844
Yoshioka, S., Fujii, W., Ogawa, T., Sugiura, K., and Naito, K. (2015). Development
of a mono-promoter-driven CRISPR/Cas9 system inmammalian cells. Sci. Rep.
5:18341. doi: 10.1038/srep18341
Young, D. D., Garner, R. A., Yoder, J. A., and Deiters, A. (2009). Light-activation of
gene function in mammalian cells via ribozymes. Chem. Commun. 1, 568–570.
doi: 10.1039/b819375d
Yumerefendi, H., Lerner, A. M., Zimmerman, S. P., Hahn, K., Bear, J. E., Strahl,
B. D., et al. (2016). Light-induced nuclear export reveals rapid dynamics of
epigenetic modifications. Nat. Chem. Biol. 12, 399–401. doi: 10.1038/pj.2016.37
Zalatan, J. G., Lee, M. E., Almeida, R., Gilbert, L. A., Whitehead, E. H., La Russa,
M., et al. (2015). Engineering complex synthetic transcriptional programs with
CRISPR RNA scaffolds. Cell 160, 339–350. doi: 10.1016/j.cell.2014.11.052
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S.,
Essletzbichler, P., et al. (2015a). Cpf1 is a single RNA-guided endonuclease of a
class 2 CRISPR-Cas system. Cell 163, 759–771. doi: 10.1016/j.cell.2015.09.038
Zetsche, B., Volz, S. E., and Zhang, F. (2015b). A split-Cas9 architecture for
inducible genome editing and transcription modulation. Nat. Biotechnol. 33,
139–142. doi: 10.1038/nbt.3149
Zhang, F.,Wang, L.-P., Brauner,M., Liewald, J. F., Kay, K.,Watzke, N., et al. (2007).
Multimodal fast optical interrogation of neural circuitry. Nature 446, 633–639.
doi: 10.1038/nature05744
Zhang, K., and Cui, B. (2015). Optogenetic control of intracellular signaling
pathways. Trends Biotechnol. 33, 92–100. doi: 10.1016/j.tibtech.2014.11.007
Zhang, L., Ward, J. D., Cheng, Z., and Dernburg, A. F. (2015). The auxin-inducible
degradation (AID) system enables versatile conditional protein depletion in C.
elegans. Development 142, 4374–4384. doi: 10.1242/dev.129635
Zhao, X.-Y., and Lin, J. D. (2015). Long noncoding RNAs: a new
regulatory code in metabolic control. Trends Biochem. Sci. 40, 586–596.
doi: 10.1016/j.tibs.2015.08.002
Zhao, Y., Dai, Z., Liang, Y., Yin, M., Ma, K., He, M., et al. (2014). Sequence-
specific inhibition of microRNA via CRISPR/CRISPRi system. Sci. Rep. 4:3943.
doi: 10.1038/srep03943
Zhou, X. X., Chung, H. K., Lam, A. J., and Lin, M. Z. (2012). Optical control
of protein activity by fluorescent protein domains. Science 338, 810–814.
doi: 10.1126/science.1226854
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Czapin´ski, Kiełbus, Kałafut, Kos, Stepulak and Rivero-Müller.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Chemistry | www.frontiersin.org 25 March 2017 | Volume 5 | Article 12
